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Abstract 
Tau protein is classically considered as a neuronal microtubule-associated protein that stabilizes 
microtubules and supports the outgrowth of axons. The protein can modulate the transport of 
vesicles and organelles along microtubules, serves as an anchor for enzymes, and regulates the 
dynamics of microtubules. Tau is an intrinsically disordered protein, which becomes excessively 
phosphorylated in Alzheimer’s disease, loses its ability to bind to microtubules and forms 
neurofibrillary tangles. 
Similar to microtubules, actin is another important cytoskeletal protein, which is involved in 
generation and maintenance of cell morphology and polarity, cell division, contractility, motility, 
and intracellular trafficking. Microtubule-associated proteins not only regulate microtubule 
dynamics but bundle actin filaments and cross-link actin filaments with microtubules. In 
addition, aberrant interaction of the microtubule-associated protein Tau with filamentous actin is 
connected to synaptic impairment in Alzheimer’s disease. Furthermore Hirano bodies, which are 
actin-rich inclusions, are found in brain histopathological samples of Alzheimer’s disease and 
related tauopathies. 
Although the interaction between Tau and actin has been studied, the nature of the interaction 
and molecular mechanism involved are still unclear. The intrinsically disordered nature of Tau in 
solution as well as the dynamic nature of Tau-actin interaction, where even in the bound state 
part of Tau remains flexible, limits the use of X-ray crystallography to investigate the structure 
of Tau bound to actin. Therefore we decided to use Nuclear Magnetic Resonance spectroscopy 
well as other biochemical and biophysical methods to understand the nature of interaction 
between Tau and actin. 
Here we provide insight into the nature of interaction between actin filaments and Tau proteins 
and the actin-microtubule crosstalk. We show that Tau uses several short helical segments to 
bind in a dynamic, multivalent process to the hydrophobic pocket of actin. Although a single Tau 
helix is sufficient to bind to filamentous actin, at least two, flexibly linked α-helices are required 
for actin bundling. In agreement with a structural model of Tau repeat sequences in complex 
with actin filaments, phosphorylation at serine 262 attenuates the binding of Tau to filamentous 
actin. Taken together the data demonstrate that bundling of filamentous actin and cross-linking 
of the cellular cytoskeleton depends on the metamorphic and multivalent nature of microtubule-
associated proteins. 
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1. Introduction 
1.1. Alzheimer’s disease 
Alzheimer’s disease (AD) is characterized as progressive brain disorder that slowly destroys 
memory and thinking skills and thereby suppresses the ability to carry out the simplest tasks. 
Around 46.8 million people worldwide were living with dementia in 2015. This number will 
almost double every 20 years, reaching 74.7 million in 2030 and 131.5 million in 2050. These 
new estimates are 12-13% higher than those made for the World Alzheimer Report 2009 (Prince, 
Wimo et al. 2015). For these reasons AD has become one of the most important health and 
socioeconomic problems. 
 
Figure 1.1. Progressive degeneration from neuronal to cerebral cortex.  
(a) Extracellular neuritic plaques (green circles) are a pathological hallmark in AD. These plaques are 
composed of the insoluble aggregates of amyloid β (Aβ), a small proteolytic fragment from the amyloid 
precursor protein. (b) Progressive neuronal death is correlated with a loss of cerebral mass in the human 
brain (Image courtesy of National Institute of Health, modified to use here). 
AD causes a large loss in brain weight and volume (Figure 1.1b) and affects some brain regions 
and neuronal populations more than others (GomezIsla, Price et al. 1996). Although AD causes 
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loss of neurons in specific brain regions the overall loss of brain mass appears to be due to the 
shrinkage and loss of neuronal processes. 
Since the time of Dr. Alois Alzheimer, neuropathologists have identified amyloid plaques and 
Neurofibrillary Tangles (NFTs) in the autopsied brains of people with AD, suggesting that these 
pathologies cause the disease (Ramirez-Bermudez 2012). Amyloid plaques are insoluble 
extracellular aggregates of Aβ around neurons (Figure 1.1a) whereas NFTs are composed largely 
of paired helical filaments of hyper-phosphorylated Tau proteins, with both of them promoting 
neuronal and synaptic loss (Anand, Gill et al. 2014). NFTs have been found not only in AD but 
also in other Tauopathies including frontotemporal dementia, progressive supranuclear palsy, 
and corticobasal degeneration (Iqbal, Alonso et al. 2005). 
1.2. Tau pathology in Alzheimer’s disease 
AD is related to the dysfunction of multiple proteins, which can adopt pathogenic conformations 
and accumulate in the brain. As mentioned before AD is associated not only with the abnormal 
accumulation of Aβ plaques, but also with that of NFTs (Figure 1.2). NFTs are intracellular 
aggregates and are made up primarily of aggregated Tau bearing abnormal posttranslational 
modifications, including hyper-phosphorylation and acetylation (Min, Cho et al. 2010, Cohen, 
Guo et al. 2011).  
 
Figure 1.2. Microtubule disassembly and formation of neurofibrillary tangles. 
Neurofibrillary tangles are aggregates of hyper-phosphorylated Tau. Tau with AD-like phosphorylation 
has an imparied ability to stabilize microtubules, destabilizing the cytoskeletal network and disrupting 
microtubule-supported cellular transport. (Image courtesy of the National Institute of Health) 
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Tau is classically considered as a neuronal microtubule-associated protein that stabilizes 
microtubules (MTs) and supports the outgrowth of axons (Weingarten, Lockwood et al. 1975, 
Drubin and Kirschner 1986). It has being suggested that Tau-induced neurodegeneration is 
mediated by a loss-of-function mechanism due to hyper-phosphorylation and sequestration of 
Tau in solution (Zhang, Maiti et al. 2005). Nevertheless this idea have being broadly discussed 
and somehow remains as an open question because of the lack of evidences (Morris, Maeda et al. 
2011) Tau may facilitate or enhance excitatory neurotransmission by regulating the distribution 
of synaptic activity-related signaling molecules (Morris, Maeda et al. 2011). However, abnormal 
modification drives to pathogenic conformations and Tau becomes enriched in dendritic spines 
where it can interfere with neurotransmission (Hoover, Reed et al. 2010). Entry of Tau into 
dendrites is correlated with a loss of dendritic spines and thus a decay of neuronal 
communication (Zempel, Thies et al. 2010). Furthermore, disruption of actin structures in growth 
cones perturbs the localization of Tau inside growth cones (Zmuda and Rivas 2000). It has also 
been found that Tau neurotoxicity correlates with alterations of actin organization in animal 
models of Alzheimer’s disease (Fulga, Elson-Schwab et al. 2007). 
Therefore, inhibition of Tau abnormalities represents a promising therapeutic approach to AD 
and other tauopathies (Churcher 2006, Aisen, Cummings et al. 2012). 
1.3. Tau Protein 
Tau is an axonal protein discovered in the mid-1970s by studying factors necessary for 
microtubule formation (Weingarten, Lockwood et al. 1975). It is an intrinsically disordered 
protein, which is part of a group of proteins called Microtubule-associated proteins (MAPs) 
(Cassimeris and Spittle 2001). MAPs are heat resistant and not affected by acid treatment, 
retaining microtubule-binding even after harsh treatment (Cleveland, Hwo et al. 1977). 
1.3.1. Tau gene 
Tau is expressed in higher eukaryotes and found in both neuronal and non-neuronal cells, but 
predominantly in neurons (Loomis, Howard et al. 1990, Martin, Latypova et al. 2011). It is most 
abundant in neuronal axons (Lee, Goedert et al. 2001), but can also be found in neuronal 
somatodendritic compartments (Tashiro, Hasegawa et al. 1997) and in oligodendrocytes (Klein, 
Kramer et al. 2002). 
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Human Tau is encoded in over 100 kb on the long arm of chromosome 17, specifically at 
position 17b21 and contains 16 exons (Figure 1.3, top panel). Exons 1, 4, 5, 7, 9, 11,12 and 13 
are constitutive exons while exons 2, 3 and 10 are alternatively spliced (Sergeant, Delacourte et 
al. 2005). Exons 0, which is part of the promoter, and 14 are transcribed but no translated. Exons 
6 and 8 are not transcribed in human brain while 4a is only expressed in the peripheral nervous 
system. 
Alternative splicing of the N-terminal region and the repeat domain generates six different 
isoforms in the central nervous system (Sergeant, Delacourte et al. 2005). Tau isoforms are 
commonly named according to the number of microtubule-binding repeat sequences (termed R) 
and whether N-terminal exons are included (termed N) (Figure 1.3). For example, 0N/3R 
correspond to hTau23 (see Figure 1.3, button panel) and 2N/3R for hTau39. 
 
Figure 1.3. Schematic representation of the human Tau gene and the six Tau isoforms expressed in 
the adult central nervous system.  
The Tau gene comprises 16 exons (upper panel) and eight of them are constitutive. Exons 2, 3 and 10 can 
be alternatively spliced giving rise to the six different Tau isoforms. Insert N2 can appear together with 
insert N1 in the projection domain (isoforms hTau40 and hTau39) but never alone. Meanwhile insert N1 
can appear alone in isoforms hTau34 and hTau37. Exons 2 and 3 are transcribed but not translated in 
isoforms hTau24 and hTau23, while exon 10 is not translated in isoforms hTau39, hTau37 and hTau23. 
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Tau can be subdivided into four regions: an N-terminal projection region, a proline-rich domain, 
a microtubule-binding domain (MBD), and a C-terminal region (Mandelkow et al., 1996).  
1.3.2. Tau phosphorylation 
Phosphorylation of Tau regulates its binding to microtubules, regulates their assembly and is 
associated with Tau aggregation in AD (Martin, Latypova et al. 2013). Phosphorylation of Tau 
around the MBD may neutralize the positive charge (Jho et al., 2010) and alter the conformation 
of the MBD of Tau (Fischer et al., 2009), detaching Tau from microtubules. 
Depending not only on the position but also on the number of phosphorylated residues, the effect 
on MT polymerization and MT binding is different. For instance, phosphorylation of residues 
such as Ser214 (Illenberger, Zheng-Fischhofer et al. 1998), Thr231 (Lu, Wulf et al. 1999, Cho 
and Johnson 2004, Sottejeau, Bretteville et al. 2015), and Ser262 (Biernat, Gustke et al. 1993) 
decreases the MT/Tau-affinity and inhibits Tau’s ability to promote MT assembly. On the other 
hand, phosphorylation of Ser202, Ser235, or Ser396 has almost no effect on MT binding and 
abolishes the tau-induced microtubule self-assemble (Utton, Vandecandelaere et al. 1997, 
Amniai, Barbier et al. 2009). 
Tau has a total of 85 residues (5 tyrosines, 45 serines, 35 threonines,) (Hanger, Anderton et al. 
2009) that can be phosphorylated either by non-proline directed kinases (PKA, PKC, MARK, 
CAMKII) (Correas, Diaz-Nido et al. 1992) or by proline-directed kinases (GSK3β, cdk5, 
MAPK, p38) (Hanger, Hughes et al. 1992, Lucas, Hernandez et al. 2001). Ser262 
phosphorylation, which is located within the conserved KXGS motif of the first MBD of Tau, 
has been suggested to be at the top of the phosphorylation cascade preceding phosphorylation of 
Ser202, Thr205, Ser396, and Ser404, and leading to Tau hyper-phosphorylation (Matenia and 
Mandelkow 2009, Bertrand, Plouffe et al. 2010). Mutation of Ser262 to alanine rescues the MT 
assembly properties of Tau, which are lost when wild-type Tau is phosphorylated by brain 
extracts. Moreover, alanine mutation on Ser262 and Ser356 residues in cell and animal models 
rescues the toxic effects of this type of phosphorylation in neuronal cells, but inhibits the 
outgrowth of neuronal processes highlighting the importance of these phosphorylation sites for 
neuronal differentiation (Yu, Polepalli et al. 2012). 
Tau can be phosphorylated in vitro at KXGS motifs by several kinases, although different 
kinases phosphorylate the different sites to different extents (Hanger, Anderton et al. 2009). 
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Efficient phosphorylation of the KXGS motifs is facilitated by the Microtubule Affinity-
Regulating Kinases (MARKs) and other members of the family of adenosine monophosphate-
activated protein kinases (Yoshida and Goedert 2012). It has been shown by NMR that MARK2 
binds to the N-terminal tail of Tau and selectively phosphorylates three major and five minor 
serine residues in the repeat domain and C-terminal tail. Structural changes induced by 
phosphorylation of Tau by MARK2 are highly localized in the proximity of the phosphorylation 
site and do not affect the global conformation of Tau (Schwalbe, Biernat et al. 2013).  
1.3.3. Tau structure 
Tau belongs to the class of intrinsically disordered proteins and exchanges between different 
conformations in solution (Jeganathan, von Bergen et al. 2006, Mylonas, Hascher et al. 2008). 
However, the polypeptide chain is not fully extended but adopts a paperclip shape, where the N- 
and C-terminal domains approach each other as well as the repeat domain (Jeganathan, Hascher 
et al. 2008). To obtain further insight into the dynamic structure of Tau in solution, NMR 
spectroscopy was used (Mukrasch, Bibow et al. 2009). Following a divide and conquer strategy, 
different Tau constructs were used to overcome the size limitation for NMR resonance 
assignment of intrinsically disordered proteins (Mukrasch, Bibow et al. 2009, Narayanan, Durr et 
al. 2010, Fauquant, Redeker et al. 2011). Based on paramagnetic resonance enhancement (PRE), 
an ensemble description of monomeric Tau in solution was then determined (Mukrasch, Bibow 
et al. 2009). The analysis showed that Tau is highly dynamic in solution, but has a distinct 
domain character with an intricate network of transient intramolecular contacts that are important 
for pathogenic aggregation (Mukrasch, Bibow et al. 2009). 
Upon binding to interaction partners such as MTs, distinct regions within the Tau protein can 
fold into stable structure. Early studies have already shown that the repeat domain and the 
neighboring proline-rich regions contribute strongly to MT binding (Butner and Kirschner 1991). 
Moreover, regions outside of the MBD may influence the spacing between MTs (Chen, Kanai et 
al. 1992). In addition, a variety of binding models of the Tau/MT complex have been proposed 
(Al-Bassam, Ozer et al. 2002, Kar, Fan et al. 2003, Makrides, Massie et al. 2004, Santarella, 
Skiniotis et al. 2004, Gigant, Landrieu et al. 2014). A Tau fragment from S208 to S324 (F4) 
adopts a U-turn like conformation when binds to a single tubulin dimer in the presence of 
stathmin. However it gets an extended conformation when stathmin is not present, promoting 
straight protofilaments in microtubules (Gigant, Landrieu et al. 2014). More recently, in our lab, 
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Kadavath et al. found that Tau binds microtubules through short sequence motif at the interface 
between α-β-tubulin heterodimers (Kadavath, Hofele et al. 2015). Upon binding to microtubules, 
the MT-binding motifs of Tau fold into a stable hairpin-like structure (Kadavath, Jaremko et al. 
2015). This hairpin-like model is consistent with recent FRET-based studies were authors 
suggest Tau experiences local changes upon binding to tubulin heterodimers supported by its 
intrinsic flexibility (Melo, Coraor et al. 2016). Nevertheless, no evidences were found about the 
U-turn like structure reported by Giant, Landrieu et al.  
Barre and Elizer showed by using NMR that short segments of the repeat region of Tau, adopts a 
stable α-helix conformation in the presence of anionic micelles, suggesting a structural 
reorganization of the protein in membrane-like environments (Barre and Eliezer 2006). In 
addition, several labs determined that a short stretch of residues corresponding closely to a 
previously identified Paired Helical Filaments (PHF) nucleation site (von Bergen, Friedhoff et al. 
2000) exhibits a marked preference for β-strand structure (Kunze, Barre et al. 2012, Barre and 
Eliezer 2013, Huvent, Kamah et al. 2014), supporting the importance of β-sheet formation in the 
Tau aggregation process. Protease digestion and mass spectrometry experiments revealed that the 
core of PHF comprises Tau segments from the first repeat to the C-terminus separated by 
dynamic loops, which are accessible to proteolysis (von Bergen, Barghorn et al. 2006). Other 
experiments indicated that cross-β structures are present on PHF with a preferential orientation 
to the fiber axis (Giannetti, Lindwall et al. 2000, von Bergen, Barghorn et al. 2001, Berriman, 
Serpell et al. 2003). This finding was further supported by electron paramagnetic resonance 
(EPR) and solid-state NMR (ssNMR) experiments where these β-strands were found to be 
parallel oriented (Margittai and Langen 2004, Margittai and Langen 2006, Daebel, Chinnathambi 
et al. 2012). In addition the ssNMR study indicated that a well-defined rigid core from V306 to 
S324 in K19 composed of three β-strands (Daebel, Chinnathambi et al. 2012).  
1.3.4. Tau functions 
The main known function of Tau is to stabilize MTs, modulating the transport of vesicles and 
organelles along MTs (Witman, Cleveland et al. 1976, Spittaels, Van den Haute et al. 2000, 
Dixit, Ross et al. 2008, Nam and Epureanu 2017, Stern, Lessard et al. 2017). Nevertheless Tau is 
also a multifunctional protein having numerous binding partners (Uversky 2015), including 
signaling molecules, cytoskeletal elements and lipids. Tau can bind to cytoskeletal proteins and 
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regulate signaling pathways (Godoy, Rios et al. 2014) . Tau binding also activates or inhibits 
several enzymes (Morris, Maeda et al. 2011). 
Furthermore, Tau induces changes in the organization and stability of actin filaments in neurons, 
which in turn contribute to Alzheimer disease-like neurodegeneration in Drosophila and mouse 
model systems (Fulga, Elson-Schwab et al. 2007). Tau-induced actin-rich rods were found to 
induce neurodegeneration in Drosophila neurons (Fulga, Elson-Schwab et al. 2007). In the same 
study, Tau-induced neurotoxicity was found to be associated with a panneural increase in F-actin 
levels, while G-actin levels remained unchanged. 
Subpopulations of Tau interact with microtubules and actin filaments in various cell types 
(Henriquez, Cross et al. 1995). This interaction is mediated primarily by the MBD (Farias, 
Munoz et al. 2002, Yu and Rasenick 2006) and is assisted by the adjacent proline-rich domain 
(He, Wang et al. 2009). Tau also cross-links MTs with actin filaments (F-actin) via its MBD, 
promoting in vitro co-organization and coupled growth of both networks (Elie et al., 2015;Farias 
et al., 2002).  
1.4. Actin protein 
Seven and halve decades ago, in the early 1940s, actin was first isolated from skeletal muscle. 
Scientists discovered then that actin is an essential protein for muscle contractility and can exist 
in both fibrous (F-) and globular (G-) states. It was not until 1970 when actin was also found in 
non-muscle cells and organisms - first in Acanthamoeba (Pollard, Shelton et al. 1970) and then 
in various mammalian non-muscle cells (Lazarides and Weber 1974). 
Because actin polymerizes or aggregates under crystallization conditions, the first X-ray 
structure of G-actin was solved only in 1990 (Kabsch, Mannherz et al. 1990), in complex with 
the actin binding protein DNase I which blocks actin polymerization, leading to the first atomic 
model of F-Actin (Holmes, Popp et al. 1990). 
1.4.1. G-actin 
Actin is a globular protein of around 43 kDa and is the major component of the cytoskeleton in 
eukaryotic cells (Cooper 2000). It is involved in cell motility, cargo transport, muscle 
contraction, and cytoskeletal integrity (Dominguez and Holmes 2011). Actins comprise a highly 
conserved family of proteins that fall into three broad classes: alpha, beta, and gamma isoforms 
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(Herman 1993). These isoforms differ from one another in only the first 4–5 amino acids at their 
N-terminus (Vandekerckhove and Weber 1978). Alpha actins are found in muscle tissues, which 
are an important constituent of the contractile apparatus while beta and gamma actins are present 
in most cell types as components of the cytoskeleton where they mediate cell motility. 
Nevertheless recent studies with mouse models revealed the presence of alpha-actin in 
motoneurons (Moradi, Sivadasan et al. 2017).. 
G-actin is globular has 375 amino acids with dimensions around 67×40×37 Å, contains a bound 
nucleotide and can exist in the ATP, ADP-Pi or ADP form (Bugyi and Carlier 2010). 
 
Figure 1.4. Comparison between ATP- and ADP-bound actin crystal structures.  
(a) Crystal structure of ATP-bound actin where the different subdomains are labeled from 1 to 4. ATP 
molecule appears at the nucleotide-binding pocket with a bluecolor and having a divalent cation (Mg2+) 
bound to it (dark yellow). (b) Superposition of ATP-bound (light blue) and ADP bound (cyan) actin. 
Nucleotides are not shown for clarity. Structures are nearly the same except for the loop nearby the 
nucleotide binding (arrowhead) and the small  α-helix in subdomain 2 in case of ADP-actin. The loop or 
the short helix on subdomain 2 was built on Pymol because it is not resolved in these crystal structures. 
PDB codes are indicated (Rould, Wan et al. 2006). 
G-actin consists of two major domains: the small and the large domains, which are again divided 
into subdomains 1, 2, 3 and 4 (Figure 1.4). A nucleotide (ATP or ADP) is positioned deep inside 
the cleft between subdomain 2 and 4. This region is also a binding site for many actin-binding 
proteins (Dominguez 2004) and small toxins like latrunculins (Yarmola, Somasundaram et al. 
2000). The outer part of subdomain 2 (D-loop; residues 40–51), is disordered in most X-ray 
structures of actin published to date, but has been also observed in a α-helix, β-turn, and various 
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loop conformations especially in presence of ADP (Figure 1.4b). Both the N- and C-termini of 
actin are located in subdomain 1, albeit on opposite faces of the molecule. Similar to the D-loop, 
N- and C-termini are flexible and are often disordered in X-ray structures. 
G-actin can exist in different conformations, depending on the status of the actin-bound ATP, the 
nature of the divalent cation (Ca2+ or Mg2+) at the high-affinity site or at additional sites, and the 
degree of oligomerization (Moraczewska, Wawro et al. 1999, Schuler 2001). Assuming an 
invariant, diffusion-limited association rate constant of 6*106 M-1s-1, Ca2+-actin binds ATP 
several times stronger than Mg2+-actin (Frieden 1982, Kinosian, Selden et al. 1993) 
The hydrophobic pocket of actin is considered to be one of the most important binding sites and 
it is recognized by most of the actin binding partners (Bobkov, Muhlrad et al. 2002, Dominguez 
2004, Hertzog, van Heijenoort et al. 2004, Chereau, Kerff et al. 2005, Didry, Cantrelle et al. 
2012). This pocket is comprised between subdomains 1 and 3, sometimes referred as the barbed 
end when actin is assembled into filaments. 
1.4.2. F-actin 
Actin Filaments are found in most eukaryotic cells as constituents of the cytoskeleton. They play 
a central role in various types of motility (including muscle contraction) and transport processes. 
Holmes and co-workers were the first to propose an atomic model of F-actin, i.e., the Holmes-
Lorenz model (Holmes, Popp et al. 1990, Lorenz, Popp et al. 1993).  
Later, Schutt and colleagues have constructed an alternative atomic model of F-actin derived 
from the structural analysis of bovine profilin β-actin co-crystals (Schutt, Rozycki et al. 1995, 
Schutt, Kreatsoulas et al. 1997). Their model is slightly different from the Holmes-Lorenz 
model, although it is corroborated by the same structural constraints as were used to build and 
refine the former model. 
More recently, thanks to advances in cryo-electron microscopy (Cryo-EM) better resolved 
structural models of F-actin became available (Fujii, Iwane et al. 2010, Galkin, Orlova et al. 
2011). Recently a Cryo-EM-based three-dimensional structure of F-actin at a resolution of 3.7 Å 
in complex with tropomyosin was reported (von der Ecken, Muller et al. 2015). 
Within actin filament the distance between subunits on adjacent strands is 27.3 Å with a rotation 
of 166.15° around the axis (Egelman, Francis et al. 1982, Fujii, Iwane et al. 2010). Filaments are 
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flexible, and have a helical repeat every 37 nm, ranges from 5-9 nm in diameter with 13 actin 
subunits between each crossover point (Egelman 1985, Egelman 2003). 
1.4.2.1. F-actin assembly 
The actin filament is functionally and structurally asymmetric, which in vitro is reflected in a 
difference in the rate of addition of actin monomers at both ends. It is composed of numerous 
individual actin subunits bound together to form a polar double-stranded structure (Oda, Iwasa et 
al. 2009). The polymerization process occurs in three different sequential phases (Figure 1.5). 
The first phase is marked by a latency period in which G-actin aggregates into short, unstable 
oligomers that are more likely to rapidly dissociate to monomers than to assemble. Once the 
oligomers reach a certain size (three to four monomers) it is used as a seed from which an 
elongation process (second phase) takes place. In this phase actin monomers are added to both (–
) and (+) ends where actin assembly is more likely than disassembly. As long as the actin 
filaments grow, the concentration of G-actin monomers decreases until it is in equilibrium with 
the filament. This third phase is called “steady state” or “treadmilling” because G-actin 
monomers exchange with subunits at the filament ends but there is no net change in the total 
mass of filaments. At this stage ATP-actin is more efficiently incorporated at the (+) end than to 
the (–) end therefore the filament elongation takes place over the (+) end.  
 
Figure 1.5. The three different phases of actin polymerization.  
During the initial nucleation phase, ATP-actin monomers (pink) slowly form stable trimeric or tetrameric 
complexes of actin (purple) called nucleus. These nuclei are more rapidly elongated in the second phase 
by addition of subunits to both ends of the filament. In the steady state, the filament dynamics enter a 
state of equilibrium where monomer disassembly from the (–) end and polymerization at the (+) end is 
balanced and maintained by a critical concentration of monomers in the cytosol. After their incorporation 
into a filament, subunits slowly hydrolyze ATP and become stable ADP-F-actin (yellow). Blue circles 
highlight ATP-binding clefts 
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In vivo elongation at the barbed end is 10-to 20- fold faster than at the slow polymerizing pointed 
end. Therefore the polymerization occurs with higher efficiency at the barbed end (Bugyi and 
Carlier 2010). Thus, during the initial phase of polymerization in vitro, in the presence of excess 
ATP, ATP-actin is rapidly and preferentially incorporated into filaments at their barbed end 
creating a ‘cap’ rich in ATP-subunits (Pollard, Blanchoin et al. 2000). 
A minimum concentration of monomers in the cytosol is needed for the actin polymerization to 
occur; this is known as critical concentration (Cc). The Cc depends on the isoform of actin, the 
nucleotide and divalent cation bound in the nucleotide cleft, solvent conditions (pH, ionic 
strength, temperature, etc.), and the presence of other actin binding proteins or factors. When the 
concentration of free subunits exceeds the Cc, filament elongation occurs spontaneously (Carlier 
and Pantaloni 1997). For the (+) end the Cc is assumed to be ~ 0.1 µM whereas in the (–) end it 
is ~ 0.8 µM (Lodish H 2000). At the steady state, which is achieved when the rate of filament 
polymerization is equally balanced by filament disassembly, the free subunit concentration is 
higher than the Cc at the (+) end and lower than the Cc at the (–) end. As a result subunits are 
added to the (+) end and dissociates from the (–). 
1.4.3. Actin partners 
The dynamic behavior and the organization of the actin cytoskeleton are regulated by numerous 
actin-binding proteins, responsible for nucleating, binding to G- and F-actin, severing F-actin, 
capping its end, and bundling filaments (Sokolov, Spooner et al. 1999, Galkin, Orlova et al. 
2011) 
1.4.3.1. G-actin partners 
Different G-actin binding drugs and proteins have been identified (dos Remedios, Chhabra et al. 
2003, Dominguez 2004). There are at least four different families of proteins that bind primarily 
to actin monomers. G-actin binding proteins are very important in nature because they are part of 
the machinery needed for modulating the polymerization rate by controlling the amount of G-
actin in the cytosol. Other proteins including profilin mediate phosphorylation of ADP-actin 
(Nishida 1985, Vinson, De la Cruz et al. 1998) and therefore play an important role in the 
treadmilling process. 
The pancreatic secretory protein DNase-I binds to most G-actin isoforms with a dissociation 
constant of 5*108 M-1 (Mannherz, Leigh et al. 1975, Mannherz, Goody et al. 1980). It binds to 
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the D-loop and inhibits nucleotide binding, because of its proximity to the nucleotide binding site 
as well as the conformational changes in actin upon binding (Kolli, Wojes et al. 2008). 
The best-studied sequestering G-actin binding proteins belong to the Thymosin family. These 
proteins act by clamping ATP-actin top to bottom capping the actin monomers at both barbed 
and pointed ends and preventing incorporation into filaments (Hertzog et al., 2004; Irobi et al., 
2004). More recently the structure of Thymosin-β4 (Tβ4), the major variant of β-thymosins, in 
complex with actin was determined by NMR (Didry, Cantrelle et al. 2012). Tβ4 is known to be 
unstructured in solution but adopts α-helical conformation upon binding to actin (Zarbock, 
Oschkinat et al. 1990, Hertzog, van Heijenoort et al. 2004, Didry, Cantrelle et al. 2012).  
 
Figure 1.6. Crystal structure of actin in complex with ciboulot.  
Latrunculin B is represented with red spheres and is bound to the nucleotide-binding pocket of the actin 
molecule (pink). Hydrophobic residues from ciboulot involved in binding are highlighted (right panel) 
(PDB id 1SQK (Hertzog, van Heijenoort et al. 2004)). 
The actin-binding motif of β-thymosins are also found in various modular proteins, where it is 
called WH2 (WASP Homology 2) domain, because it was first recognized in proteins of the 
WASP (Wiskott-Aldrich Syndrome Protein) family. Some of these proteins consist of two or 
more β-thymosin repeats. ciboulot (Cib) is a protein from Drosophila, which has three different 
domains (D1, D2 and D3) (Boquet, Boujemaa et al. 2000). In spite of its sequence similarity with 
β-thymosin Cib displays a profilin-like function promoting barbed-end actin assembly while 
inhibiting pointed-end growth (Boquet, Boujemaa et al. 2000, Hertzog, Yarmola et al. 2002). It 
has been shown that the first domain of Cib (D1) interacts with actin and possesses the 
biochemical and motile activities of the full-length protein (Hertzog, van Heijenoort et al. 2004). 
Despite the fact that no ADP-actin binding activity has been reported so far, Cib binds with a 
high affinity to ATP-actin (Kd=3 µM) (Hertzog, Yarmola et al. 2002) adopting an  α-helical 
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conformation upon binding (Figure 1.6). This interaction is mainly hydrophobic (Hertzog, van 
Heijenoort et al. 2004) and apparently all the hydrophobic residues on the N-terminus are 
contributing to the interaction. 
The binding site of Cib on actin surface is typically referred as hydrophobic pocket of actin 
(Dominguez 2004) and it forms the binding site for several other proteins including gelsolin, 
cofilin, profilin. All these proteins adopt an amphipathic α-helical conformation upon binding to 
actin (Dominguez 2004). 
In addition to the identified G-actin-binding proteins, small molecules can also bind to actin. 
Despite the fact that most of them cannot be used for pharmacological treatments due to the 
inability to enter the cell, they are still widely used in research. Kabiramide, latrunculin and 
swinholide are known to bind to monomeric actin; however, the binding site and binding mode 
are different.  
Swinholide A, a molecule isolated from marine sponges, is a 44-carbon ring dimeric dilactone 
macrolide with a 2-fold axis of symmetry (Figure 1.7a). This molecule sequester actin dimers in 
vitro in both polymerizing and non-polymerizing buffers in a binding stoichiometry of one 
swinholide molecule per actin dimer (De Marino, Festa et al. 2011). Swinholide A also severs F-
actin with high cooperativity. The crystal structure of this complex is shown in Figure 1.7b. 
Kabiramide C, is a marine toxin of Trisoxazole family that binds to actin with a dissociation 
constant of 100 nm or less (Tanaka, Yan et al. 2003). The X-ray structure in complex with actin 
(1QZ5) is already available (Stricker, Falzone et al. 2010). The 3D structure reveals that the 
molecule interacts with subdomains 1 and 3 of actin (medium panel, Figure 1.7d). Despite the 
fact that molecules of the Trisoxazole family bind to the hydrophobic pocket of actin, they act 
similar to gelsolin (Galkin, Orlova et al. 2010) and profilin (Torres-Cruz, Rodriguez-Cruz et al. 
2016) inhibiting the nucleotide exchange on actin. This effect may be related to the fact that the 
binding of kabiramide C may increase the rigidity of actin, which prevents the normal “open” 
and “close” of the nucleotide-binding pocket (Klenchin, Allingham et al. 2003). 
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Figure 1.7. Small molecules and their complexes with G-actin.  
(a) Chemical structure of swinholide A. (b) Cartoon representation of two actin molecules (pink) cross-
linked by swinholide (yellow spheres). (c, e) Chemical structures of kabiramide C and latrunculin B 
respectively, with crystal structures in complex with actin presented in (d) and (f). Kabiramide C in grey 
binds on the hydrophobic pocket of actin, while latrunculin B (blue light spheres) blocks nucleotide 
(yellow) exchange on the nucleotide-binding cleft. 
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Unlike kabiramide and swinholide, latrunculin molecules, isolated from the red sea sponge 
Negombatamagnifica, bind directly to the nucleotide exchange cleft between subdomains 2 and 4 
(Guo, Shillcock et al. 2010, Dominguez and Holmes 2011) (bottom panel, Figure 1.7a). Two 
related compounds, latrunculin-A (LatA) and latrunculin-B (LatB), were shown to depolymerize 
actin structures both in vitro and in vivo (Kashman, Groweiss et al. 1980, Spector, Shochet et al. 
1983). LatA binds to G-actin in a 1:1 molar complex with an equilibrium dissociation constant of 
0.2 μM (Pollard, Blanchoin et al. 2000). The molecule lowers the affinity of actin for Tβ4 by 1 
order of magnitude, but it does not affect the binding of profilin or DNase I (Yarmola, 
Somasundaram et al. 2000). LatA acts as a sequestering agent of actin, preventing F-actin 
assembly. A review from Allingham et al. describes the molecular mechanism by which different 
actin-targeting natural products function in detail (Allingham, Klenchin et al. 2006) 
1.4.3.2. F-actin partners 
F-actin-binding proteins can be divided into three different groups depending on their effect on 
actin filament dynamics and organization. The first group is the one comprising F-actin severing 
proteins. They have the ability to break actin filaments through a non-proteolytic mechanism. 
The second group consists of proteins, which are able to bind at either end of the filament, 
inhibiting further addition of monomers, so called capping proteins. The last group interacts with 
the lateral side of filaments and can stabilize, protect or reconnect the filaments. 
Gelsolin is a Ca2+-regulated actin-binding protein that belongs to the family of actin-severing and 
actin-capping proteins, which includes adseverin, villin, CapG, advillin, and supervillin (Silacci, 
Mazzolai et al. 2004). Gelsolin is an 80-kDa protein consisting of two tandem homologous 
halves (segments 1–3 and 4–6), each containing three repeats. Segment 1 (S1) binds G-actin in 
the absence of Ca2+, and the resulting complex is able to cap actin filaments. Segments 4-6 (S4–
S6) constitute a second, Ca2+-dependent, G-actin binding fragment that competes for the same 
actin-binding site as S1. S2 binds F-actin in a Ca2+-independent manner and is able to decorate 
actin filaments. Nucleation of F-actin can be achieved with S2–S6 but the F-actin-severing 
function is performed by S1–S3 (Burtnick, Koepf et al. 1997).  
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Figure 1.8. Crystal structure of G-actin in complex with gelsolin  
Crystal structure of G-actin (pink) in complex with the subdomain S1 of gelsolin (blue) is shown (PDB id 
1EQY (Mclaughlin, Gooch et al. 1993)). The α-helix in close contact with actin is highlighted in red. In 
the right panel, hydrophobic residues from gelsolin, which are thought to be involved in binding, are 
highlighted in dark yellow. 
In Figure 1.8 the crystal structure (PDB id 1EQY (Mclaughlin, Gooch et al. 1993)) of the 
complex of the S1 subdomain of gelsolin with G-actin is presented. Major protein–protein 
contacts involve an amphipathic helix formed by Ser70–Asn89 of gelsolin and an extended 
hydrophobic cleft located between subdomains 1 and 3 of actin. The α-helix presents exposed 
hydrophobic side chains, which bind into the hydrophobic cleft of actin. 
A second important and essential family of eukaryotic actin-binding proteins is formed by 
ADF/cofilins. ADF/cofilins have long been known to play a key role in actin filament dynamics 
and to have highly complex and interesting modes of regulation. ADF/cofilins are homologous 
actin-binding proteins, which bind to the side of the filament. Thus it has an important role in 
promoting actin filament turnover, which supports different forms of cell motility (Bernstein and 
Bamburg 2010, Bravo-Cordero, Magalhaes et al. 2013). Although cofilin is known to binds F-
actin, it can also accelerate spontaneous assembly of actin monomers (Carlier et al., 1997; Du 
and Frieden, 1998; Yeoh et al., 2002)  
  
 
Introduction 
 
  
18 
 
Figure 1.9. Concentration-dependent activity of cofilin.  
Filaments remain stable in absence of cofilin. At low concentration, cofilin (blue circles) breaks the 
filaments up in shorter filaments. At higher concentrations of cofilin, cofilin binds to F-actin in a 
cooperative way promoting release of inorganic phosphate (Pi). At very high concentrations of cofilin, 
cofilin binds to G-actin and promotes filament assembly. 
At low ratios with respect to actin subunits in F-actin (<1:100), cofilin severs F-actin forming 
more filament ends that can either nucleate filament growth or quickly depolymerize filaments, 
depending on the amount of available G-actin (Andrianantoandro and Pollard 2006). Whether 
cofilin binds the filaments depends on the release of inorganic phosphate (Pi) after actin ATP 
hydrolysis because Pi binds antagonistically with cofilin (Muhlrad, Pavlov et al. 2006). In 
addition, release of Pi is increased ~10- fold by cofilin binding (Blanchoin and Pollard 1999). 
Cofilin’s ability to depolymerize actin faster at higher pH is thought to result from the pH 
dependence of Pi release (Pavlov, Muhlrad et al. 2006), because the binding of Pi is stronger at 
low pH (6.5) than high pH (8.0) (Muhlrad, Pavlov et al. 2006). At higher cofilin-to-actin molar 
ratios, cofilin severs rapidly but transiently because it binds F-actin cooperatively and stabilizes 
F-actin in a twisted form as it saturates the severed pieces (Ni and Scheraga 1994) (Figure 1.9). 
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Figure 1.10. 3D structures of cofilin in complex with F-actin and in solution.  
(a) Cofilin molecules (blue light) bind to the actin filament (pink) surface and decorate it (Hertzog, van 
Heijenoort et al. 2004). (b) Cartoon representation of human cofilin in solution. α-helix 4, which is 
involved in binding to actin, is colored in red. Side chains of residues important for binding are 
highlighted (Bernstein and Bamburg 2010) 
In 2003, Pope et al determined the 3D structure of human cofilin in solution (Pope, Zierler-
Gould et al. 2004). The N-terminal part of the long α4-helix of cofilin (Figure 1.10b) is involved 
in binding to the hydrophobic pocket of G-actin between subdomains 1 and 3 (Gronenborn 1983)  
(Pope, Zierler-Gould et al. 2004, Macchi, Rudd et al. 2016), and site-directed mutagenesis 
identified Lys112 and Lys114 in α4 as essential for G-actin binding (Hetenyi, Hegedus et al. 
2016, Macchi, Rudd et al. 2016). Synchrotron protein foot printing identified residues in yeast 
cofilin corresponding to Met115 G-actin binding (Tang, Huang et al. 2016). According to the 3D 
structure of the cofilin/F-actin complex derived from Cryo-EM, the binding region on F-actin is 
the same (Galkin, Orlova et al. 2011). This is because the hydrophobic pocket of actin is exposed 
to the solvent on the filament surface (Dominguez 2004). Figure 1.10a shows how cofilin 
decorates the actin filament surface.  
Another group of F-actin-binding proteins include Arp2/3, α-actinin, vinculin, fascin, fimbrin, 
spectrin and filamin. They interconnect filaments in many different ways providing several 
functionalities within the cell. Arp2/3, for example, is a 7-subunit protein complex, which builds 
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cross-linked actin networks facilitating cell movement. Arp2/3 builds these networks by binding 
to the sides of existing actin filaments and nucleates growth of new filaments from their sides. 
Small molecules have also been reported to bind to and stabilize actin filaments. Some of these 
molecules are phalloidin (Cooper 1987), jasplakinolide (Bubb, Spector et al. 2000, Minamide, 
Striegl et al. 2000) and chondramide (Kunze, Jansen et al. 1995, Sasse, Kunze et al. 1998). While 
all three substances have the capacity to stabilize F-actin, phalloidin is not membrane permeable, 
while jaslplakinolide and chondramides readily enter cells (Sawitzky, Liebe et al. 1999). 
Therefore, phalloidin is used in cell biological research mainly for visualization of F-actin after 
fluorescence labeling of the compound in fixed tissues (Peterson and Mitchison 2002). In 
contrast, the commercially available jasplakinolide can be used for F-actin stabilization in living 
cells due to its membrane permeability (Matthews, Smith et al. 1997). 
On the other hand cytochalasins, a group of fungal metabolites, binds to the (+) end of F-actin 
and slow down the rate of filament formation by inhibiting the rate of elongation (Holzinger and 
Blaas 2016). Cytochalasin D (CD) binds to F-actin with a stoichiometry of one CD per actin 
filament with a very high affinity (Kd ~ 2 nM) (Cooper 1987) and inhibit the interaction between 
cofilin and F-actin (Shoji, Ohashi et al. 2012). CD also binds to monomeric actin but with lower 
affinity (2-20 µM) (Goddette and Frieden 1985) and competes with cofilin for binding to G-actin 
(Shoji, Ohashi et al. 2012). 
1.4.4. F-actin stability and neurodegeneration 
The actin cytoskeleton plays an essential role in diverse cellular processes ranging from motility 
to division. A key control point in the cycle of F-actin assembly is the pool of actin binding 
proteins that mediates F-actin turnover in response to several signaling factors. Nevertheless, the 
stability and/or plasticity of the filament network is vital for particular cell functions. One of 
these cases is the synaptic process into the neuronal spines (McConkey BJ 2002). 
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Figure 1.11. Actin organization in neuronal spines and filopodium.  
(a) Stability of dendritic spines depends on the stability of F-actin network which is modulated for the 
presence of capping and severing proteins like the Arp2/3 complex. In filopodium actin filaments 
organizes up more in bundles of parallel filaments thanks to the presence of several cross linking proteins 
as shown in (b). 
Early electron microscopy studies have shown that actin is the major cytoskeletal component of 
dendritic spines (Tang, Huang et al. 2016). Provided that chemical synapses regulate the electric 
communication within neural networks, a precise control of the development and connectivity of 
synapses is critical for accurate neural network activity and normal brain function. Actin 
stabilizes post-synaptic proteins in mature spines (Viegas, Manso et al. 2011) and modulates 
spine head structure in response to postsynaptic signaling (Ni and Scheraga 1994) as shown in 
Figure 1.11a. The actin cytoskeleton within a spine is dynamic (Fischer, Kaech et al. 1998), 
although it also contains a small population of relatively stable actin filaments (Star, 
Kwiatkowski et al. 2002). 
In migrating cells, the barbed ends of F-actin induce cell shape changes by pushing the plasma 
membrane forming sheet- and rod-like extensions termed lamellipodia and filopodia, 
respectively (Macchi, Rudd et al. 2016). Spines contain short and highly ARP2/3-promoted 
branched actin filaments(van Zundert, Rodrigues et al. 2016), whereas filopodia consist of long, 
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unbranched, actin filaments arranged in tight, unipolar, parallel bundles (Figure 1.11b) 
(Gronenborn 1983). 
In mature spine, the base, neck, and head all consist of a mixture of branched and linear actin 
filaments; the neck contains different ratios of both linear and branched filaments, whereas most 
branched actin filaments localize to the distal regions of the spine head (Ni 1994). Actin 
filaments in the spine head are very dynamic and show a high turnover by continuous 
treadmilling (Post 2003). In this way the actin cytoskeleton of mature dendritic spines, especially 
of the spine head, seems like actin structures found in lamellipodia. Organization of F-actin 
inside spines determines the size of the spine head, which is thought to be related to the function 
of the spine. The largest ones are memory-related while the small ones are learning-related 
spines (Kasai, Matsuzaki et al. 2003) 
As reviewed by Peter Penzes and Jon-Eric VanLeeuwena (Penzes and VanLeeuwen 2011) 
depolymerization of actin leads to spine loss as well as loss of glutamate receptors from synaptic 
sites. Synapse loss is a prominent and consistent finding in postmortem tissue samples from 
patients diagnosed with AD (Ozer and Halpain 2000, Whiteman, Gervasio et al. 2009). 
The connection between F-actin stability and spine durability is increasingly recognized 
(Calabrese, Wilson et al. 2006, Makioka, Yamazaki et al. 2014). In addition, the dynamics of the 
F-actin network is controlled by members of the Rho-family GTPases, a subgroup of the Ras 
superfamily of GTPases (Mayer and Meyer 1999, Carlomagno 2005) through transmembrane 
signaling mechanisms. This signaling mechanism regulates the function of different proteins that 
regulates F-actin turnover. Once this mechanism is disrupted, F-actin spine stability is 
compromised leading to memory impairment and neuronal degeneration. 
1.5. Tau and actin interaction 
Although Tau is considered a microtubule-associated protein it can also be considered an actin 
binding protein. Either in vivo or in vitro conditions Tau can bind to both G-actin and F-actin 
(He, Wang et al. 2009, Zempel, Luedtke et al. 2013). Tau-induced actin-rich rods were found to 
induce neurodegeneration in Drosophila neurons (Fulga, Elson-Schwab et al. 2007). In the same 
study, Tau-induced neurotoxicity was found to be associated with a panneural increase in F-actin 
levels, while G-actin levels remained unchanged.  
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It has also long been reported that Hirano bodies, which are actin-rich paracrystalline inclusions, 
are found in brain histopathological samples of Alzheimer’s disease and related Tauopathies 
(Dominguez, Boelens et al. 2003, Makioka, Yamazaki et al. 2014). Further supporting 
information about the effect of Tau on actin dynamic it was recently proved by fluorescence 
microscopy that Tau-induced remodeling of the actin cytoskeleton is involved in plasma 
membrane blebbing (Torres-Cruz, Rodriguez-Cruz et al. 2016) 
1.5.1. Tau regions involved in binding to actin 
Several authors reported Tau and actin interaction from some time ago (Griffith and Pollard 
1978, Pedrotti, Colombo et al. 1994). In 1990, Isabel Correas et al, showed that an amino acid 
sequence of Tau involved in the binding of Tubulin is also involved in actin binding (Merlini, 
Wanner et al. 2016). In the analysis they used affinity chromatography of G-actin on a column 
containing the synthetic peptide, and the co-sedimentation and co-localization of F-actin and the 
peptide. Furthermore, Yamauchi et al suggested that the interaction of Tau and F-actin is weaker 
than in case of microtubule although in both cases interaction has an electrostatic nature 
(Yamauchi and Purich 1993). 
In 1993 Moraga et al found by means of electron microscopy that even sort Tau fragments from 
the MBD are able to bind actin and promote bundles formation (Moraga, Nunez et al. 1993). 
Later it was found that the C-terminal of Tau associates with actin in different PC12 while the N-
terminal part may play a regulatory role in this process (Yu and Rasenick 2006). MAP2 also bind 
to actin filaments by their microtubule-binding domains while in case of Tau the proline-rich 
domain is also involved in binding (Pedrotti, Colombo et al. 1994, He, Wang et al. 2009). A 
synthetic Tau peptide consisting of one microtubule-binding sequence binds to both G- and F-
actin, but could not bundle actin filaments. This observation suggests that more than one 
microtubule-binding sequence of Tau is required to bundle actin filaments (Merlini, Wanner et 
al. 2016).  
Molecular dissection studies revealed that the actin-binding site on MAP4 is situated at the C-
terminal part of the proline-rich region, where the microtubule-binding site is also located 
(Correas, Padilla et al. 1990). Electron microscopy revealed that the MAP4-bound actin 
filaments become straighter and larger and that the number of actin bundles increases with 
greater concentrations of added MAP4 fragment. A multiple sequence alignment of the proline-
rich regions of MAP4 and Tau revealed two putative actin-binding consensus sequences. 
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1.6. Tau-mediated microtubule F-actin interaction 
Cytoskeletal network is a very important for cells support and motility. The cytoskeleton is 
composed of three types of polymers: microtubules, actin, and intermediate filaments. Each of 
these polymers is associated with a large number of accessory proteins, which can regulate the 
assembly properties of these polymers mediating interactions among themselves as well as with 
other cellular structures, including plasma membrane, organelles, and chromosomes. 
Interaction between actin filaments and microtubules is important for various cellular processes 
such as cell division, vesicle and organelle transport, axonal growth and migration (Detmers, 
Weber et al. 1981). F-actin and MTs can be cross-linked either directly by cross-linking proteins 
or indirectly via protein complexes or signaling molecules. Interactions mediated by cross 
linking proteins are usually considered to be static interactions, whereas the ones mediated by 
motor protein complexes or signaling molecules are thought to be dynamic in nature.  
MAPs are key players in mediating interactions between MTs and F-actin (Spears, Furgerson et 
al. 2014). For instance, Tau proteins mediate interactions between microtubules and actin in the 
neuronal growth cones where Tau-mediated cytoskeletal interactions promote morphological 
changes. During axonal development, Tau accumulates into the distal ends of the axon 
depending on the MT and F-actin organization (Yasunaga and Wakabayashi 2001) while the 
presence of Tau is also required for reorganization of actin and MTs for the formation of cellular 
processes in insect Sf9 cells (Mandelkow and Mandelkow 1995). 
Combined differential centrifugation and Co-sedimentation assays showed that Tau 
simultaneously binds to microtubules and actin filaments while life TIRF microscopy revealed 
that Tau coordinates dynamic microtubules and actin filaments (Elie, Prezel et al. 2015). 
Although the Tau-mediated interaction between MTs and F-actin became a common factor 
between scientists nowadays (Griffith and Pollard 1982, Selden and Pollard 1983) the 
mechanism of this interaction is still enigmatic.  
1.7. Protein NMR Spectroscopy 
Nuclear magnetic resonance (NMR) and X-ray crystallography are the most popular methods 
that can be applied to the study of three-dimensional molecular structures of proteins at atomic 
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resolution. Unlike X-ray crystallography NMR spectroscopy allows to investigate the protein 
structures in nearly physiological conditions. In addition NMR spectroscopy is a very useful 
method for the study of kinetic reactions and properties of proteins at the atomic level. In 
contrast to most other methods, NMR spectroscopy studies chemical properties by studying 
individual nuclei. It can be applied to structure determination of proteins in the size range 
between 5 and 25 kDa. Traditionally NMR spectroscopy has been limited to relatively small 
proteins or protein domains. This is in part caused by problems resolving overlapping peaks in 
larger proteins, but this has been alleviated by the introduction of isotope labeling and 
multidimensional experiments. 
1.7.1. Relevance of structure determination using NMR 
In nature, many biological processes are regulated by protein interactions. For having more 
insight in understanding the process that undergoes proteins interaction, structural analysis at 
atomic resolution is very useful. NMR, X-ray crystallography and more recently Cryo-EM are 
the widely used techniques for structural analysis of biomolecules. In case of molecules of high 
molecular weight X-ray crystallography is most suitable if crystallization is possible.  
For a characterization of internal dynamics of biomolecular structures, NMR provides direct, 
quantitative measurements of the frequencies of a certain energy motional process. In 
comparison, X-ray structure determination may include an outline of the conformational space 
covered by high frequency structural fluctuations. Furthermore, neutron diffraction in single 
crystals and NMR in solution can both be employed for studies of the exchange of labile protons, 
thus potentially enabling direct comparison of molecular dynamics in the different states.   
The study of the protein-protein interactions is becoming more relevant to study molecular 
complexes. The involvement of protein interactions with its partner protein, peptides and drugs 
makes it important to study them at a molecular level which thereby helps in understanding the 
molecular basis of diseases. 
1.7.2. NMR-based Structure determination  
The conventional 2D 1H NMR methods like Total Correlation Spectroscopy (TOCSY), Nuclear 
Oberhausen Effect Spectroscopy (NOESY) and the typical 3D experiments like HNCA, 
HNCACO, HNCACB etc. are very useful in NMR spectrum assignment. Nevertheless this 
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method becomes ineffective when assignment of proteins with molecular masses greater than 
approximately 30kDa is required. The number of hydrogen atoms present in proteins resonances, 
the correlation time (τc) of the protein and the line-widths of the NMR increases approximately 
linearly with molecular mass. 
One of the approaches that may help is reducing the unfavorable transverse relaxation pathways. 
The Total Relaxation Optimization Spectroscopy (TROSY) experiment (Biernat, Wu et al. 2002) 
provides one illustration of this principle. Its implementation, together with other methodologies 
brought the NMR size limitation near 100 kDa (Knops, Kosik et al. 1991, Gustke, Trinczek et al. 
1994).  
Protein deuteration is another approach that together with TROSY or 3D NMR-based 
experiments is sometimes necessary. The two commonly used labeling strategies are 
perdeuteration and random fractional deuteration. Perdeuteration is the one that replaces ~99% of 
all carbon-bound hydrogen atoms with deuterium atoms. Random fractional deuteration 
describes the distribution of deuterium throughout all protein molecules in the sample. For 
example, when a protein is 60% randomly deuterated, on average, 60% of the protons in the 
sample have been replaced by deuterium, but this 60% is not the same in each molecule (Butner 
and Kirschner 1991). 
NMR-based 3D structure determination of biomolecules is usually performed by distance and 
geometry calculations combined with simulated annealing (Andronesi, von Bergen et al. 2008, 
Daebel, Chinnathambi et al. 2012). Structural constraints can be derived from NOES, J-coupling, 
Cross-correlated Relaxation (CCR), Residual Dipolar Couplings (RDC) or Pseudo Contact Shift 
(PCS) into the Paramagnetic Resonance Enhancement (PRE) approach. The decision on what 
method should be used will depend on the time scale of the chemical or conformational 
exchange processes.  
For studying protein-ligand interaction the analysis can be performed by focusing either in the 
signal resonances of the protein or in the one from the ligand. In case the target is isotopically 
labeled and its size is suitable for NMR, the mapping of the binding site is possible by means of 
the Heteronuclear Single Quantum Correlation (HSQC) experiment (Goode and Feinstein 1994). 
The same approach can be used for the target in case that the isotopically labeling is possible. 
When the labeling is not feasible other methods like Saturation Transfer Difference 
(STD)(Viegas, Manso et al. 2011), transferred NOE (tr-NOE), transferred RDC (tr-RDC) and 
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transferred CCR (tr-CCR) can be used. These methods are strongly depending not only on the τc 
of the ligand but also on the affinity range of the interaction (millimolar range). 
1.8. Aim of the study 
In this chapter we have described the importance of the interaction of the microtubule-associated 
protein Tau with cytoskeletal actin for cell functionality. Any disturbance of this interaction may 
contribute to neuronal toxicity and therefore neurodegeneration. Consistent with this hypothesis, 
the mechanism of Tau toxicity might involve not only the microtubule system but also 
interference with other cellular machines and compartments such as molecular chaperones, the 
nucleus and the actin cytoskeleton (Alonso, Beharry et al. 2016). 
Although the interaction between Tau and actin has been studied for several years, the nature of 
interaction and molecular mechanisms involved are still unclear. It is important to know which 
region or regions of Tau are involved in binding and whether there is change in conformation of 
Tau upon binding to actin. In order to establish the molecular mechanism of Tau-mediated 
dysregulation of F-actin and the actin network, it is crucial to identify the binding site of Tau on 
the actin surface. 
The intrinsically disordered nature of Tau in solution as well as the dynamic nature of the Tau-
actin interaction, where even in the bound state part of Tau remains flexible, limits the use of 
Xray crystallography to investigate the structure of Tau bound to actin. Therefore we decided to 
use NMR spectroscopy as the major tool, because NMR spectroscopy allows the description of 
even highly dynamic proteins and protein complex at high resolution.  
Besides the ability of MAPs to bind to and regulate the dynamic instability of microtubules, 
MAPs bundle F-actin and cross-link the cellular cytoskeleton formed by microtubules and actin 
filaments. Little is known, however, about the molecular nature of Tau-mediated cross-linking of 
MTs and F-actin. The aim of my PhD thesis was therefore to provide detailed structural insight 
into the Tau/F-actin complex, the involved binding sites, the mechanism of F-actin bundling and 
cross-linking of the two major cytoskeleton components. 
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2. Materials and Methods 
2.1. Buffers 
Table 2.1. Names and descriptions of all the buffers used in this study 
Buffers names Buffers content 
General actin buffer  
(GAB) 
5mM TrisHCl pH 8.0, 0.2mM CaCl2, 0.2 mM ATP, 0.5mM DTT 
Polymerization buffer  
(PB) 
100mM TrisHCl pH 7.5, 20mM MgCl2, 500 mM KCl, 10mM ATP 
NMR buffer 50mM NaH2PO4 /Na2HPO4 pH 6.8, 10mM NaCl, 1mM DTT, 10% 
(v/v) D2O 
Loading buffer blue (2X) 0.5M Tris-HCl (pH 6.8), 4.4% (w/v) SDS, 20% (v/v) glycerol, 2% 
(v/v) 2-mercaptoethanol, and bromophenol blue in distilled water 
Lysis buffer  
(LB): 
50 mM Mes, 500 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 5 mM 
DTT, pH 6.8 
FPLC buffer 20 mMMes, 50 mM NaCl, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 
0.1 mM PMSF, pH 6.8 
Elution buffer 
(EB) 
20 mM Mes, 1 M NaCl, 1 mM EGTA, 1 mM MgCl2, 2 mM DTT, 
0.1 mM PMSF, pH 6.8 
Separation buffer 
(SB) 
137 mM NaCl, 3 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 
7.4, 1 mM DTT 
Boiling-extraction buffer 
(BEB) 
50 mM MES, 500 nM NaCl, 1mM MgCl2, 1 mM EGTA, 5 mM 
DTT, pH 6.8 Phosphorylation buffer 25 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (pH 
8.0), 100 mM NaCl, 5 mM MgCl2, 2 mM EGTA, 1 mM DTT, 1 mM 
benzamidine, 0.5 mM phenyl - methanesulfonyl fluoride (PMSF), 
and 1 mM ATP  
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2.2. Chemical compounds 
Cytochalasin D (Cat. No. 10-2071) and latrunculin B (Cat. No. 10-4303) were bought from 
Focus Biomolecules company whereas 1,4-Dithiothreitol (DTT) (Cat. No. D9779-50G) and 
Adenosine triphosphate (ATP) (Cat. No. 10127531001) were purchased from Sigma Aldrich. 
2.3. Protein preparation and purification 
Cloning, expression and purification of wild-type (wt) hTau40, MARK2-phosphorylated hTau40 
(pTau) and K18 were performed by Dr. Jacek Biernat in the lab of Prof. Dr. Mandelkow, DZNE, 
Bonn, Germany. MARK2-phosphorylated Tau was prepared as previously described in our lab 
(Schwalbe, Biernat et al. 2013). At the end of the phosphorylation process the sample was heated 
to denature the kinase.  
2.3.1. Protein expression in E.coli. 
Human Tau and K18 were expressed in the vector pNG2 (a derivative of pET-3a; Merck) in E. 
coli strain BL21(DE3) as described (Gustke, Trinczek et al. 1994). The expressed proteins were 
purified from bacterial extract by using the heat stability of Tau in combination with FPLC SP-
Sepharose ion exchange chromatography (GE Healthcare, Freiburg). 
Bacterial pellets were resuspended in BEB supplemented with protease inhibitor cocktail. Cells 
were disrupted with a French pressure cell and subsequently boiled for 20 min. The soluble 
extract was isolated by centrifugation and the supernatant was dialyzed twice against FPLC 
buffer, and loaded onto a FPLC SP-Sepharose column. Proteins were eluted using a linear 
gradient of EB. Tau breakdown products were separated in a second chromatography step by 
using a Superdex G200 column (GE Healthcare) with the Separation Buffer. 
2.3.2. Protein expression with isotope labeling 
To label the Tau proteins with 15N isotope, the E. coli cultures were grown in a M9 minimal 
medium with 15NH4Cl (1 g/liter) (Eurisotop, Saarbrücken). Subsequently, protein samples 
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uniformly enriched in 15N were prepared by growing E. coli bacteria in minimal medium 
containing 1 g/liter of 15NH4Cl exclusively.  
For isotope labeling of Tau proteins for NMR experiments, a rapid and efficient approach for 
preparing isotopically labeled recombinant proteins was used as reported by Marley, Lu et al. 
(Balaram, Bothner-By et al. 1972). This production method generates cell mass using unlabeled 
rich media followed by exchange into a small volume of labeled media at high cell density. Cells 
were induced with 0.8 mM IPTG following a short period for growth recovery and unlabeled 
metabolite clearance. 
Example for 1L E. coli culture, bacteria were grown in 1L of Luria broth at 37 ºC, upon reaching 
the optical cell density of 0.7 at 600 nm (OD600). The cells were pelleted, using an M9 salt 
solution and the pellet was resuspended in 250 ml of isotopically labeled minimal medium. The 
culture was then incubated for 1 hour to allow recovery of growth and clearance of unlabeled 
metabolites. Afterwards protein expression was induced by addition of IPTG to a concentration 
of 0.8 mM. Cells were harvested after 4 hours incubation. The expressed proteins were purified 
from bacterial extracts by methods described for non-isotopic expression. 
2.3.3. Standard 5 x M9 minimal medium without nitrogen source 
For 1L 5 x M9 salts: 
64g Na2HPO4-7H2 
15g KH2PO4 and 2.5g NaCl 
Add H2O to final volume 1L and autoclave 
2.3.4. Preparation of 500 mL M9 minimal medium 
100 mL 5 x M9 salts 
1mL 1M MgSO4 
50 µL 1M CaCl2 
1mL 100 x Basal Medium Eagle Vitamin Solution (Gibco) 
2.5 mL filter sterilized NH4Cl (0.2 g/mL) or 0.5g dry 
10 mL 20% d-glucose or 2g dry 
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2.4. Tau constructs and synthetic peptides 
The used full-length Tau as well as K18 and the synthetic Tau peptides are represented in Figure 
2.1. HTau40 is the largest human Tau isoform in the central nervous system with 441 residues. 
Tau contains two amino terminal inserts (N1 and N2), a proline-rich region divided in two sub 
regions (P1 and P2) and four repeats in the carboxyl terminal part and an additional repeat R´. 
K18 represents the 4-repeat C-terminal assembly domain and contains 128 amino acids with 
amino terminal methionine. K18 was generated using PCR on the template of hTau40 DNA 
sequence provided with NdeI and BamHI restriction enzyme recognition sites. 
 
Figure 2.1. Tau protein and Tau constructs used in this study. 
Top panel represent the largest isoform (hTau40, 2N/4R) in the human brain with 441 amino acids. K18, 
a 4-repeat construct at the C-terminal part of Tau comprises residues Q244 to E372. In addition, the Tau 
peptides Tau(211-242), Tau(254-290) and Tau(292-319) were used. The sequenes of the used peptides as 
well as ciboulot are also shown 
Tau and ciboulot peptides were synthesized by Kerstin Overkamp in the Department of 
NMR-based Structural Biology, Max Planck Institute for Biophysical chemistry, Göttingen. 
Synthesis was based on standard Fmoc-solid-phase peptide synthesis using an ABI 433A 
synthesizer (Applied Biosystem). Peptides were synthesized with acetyl- and amide protein 
groups at the N- and C-termini, respectively. Peptides were further purified by reversed-phase 
HPLC and the pure product was lyophilized. 
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2.5. Other proteins 
2.5.1. Human actin 
Non-muscle human actin was bought from Cytoskeleton Company (Catalog No. APHL99). 
Every milligram of lyophilized actin was reconstituted to 10 mg/mL by adding 100 µl of distilled 
water to be in the following buffer: GAB with 5% (w/v) sucrose and 1% (w/v) dextran. The 
sample was aliquoted and kept at -20 ºC for later usage. 
2.5.1.1. F-actin assembly 
A total of 20 µL of sample containing 0.4 mg/ml G-actin were prepared in GAB and 
supplemented with 0.2 mM ATP. The sample was then incubated on ice for 1h and centrifuged at 
14000 rpm for 20 minutes, in order to remove oligomers that might have formed during storage.  
Subsequently, the sample was supplemented with 20 µL of PB and incubated at room 
temperature for 1h to promote the polymerization of actin monomers. Subsequently, the sample 
was centrifuged at 100000 g for 1h at 4 ºC by using a Beckman Airfuge (rotor TLA 100.3) 
collecting the filaments at the bottom of the ultracentrifuge tube. Filaments were then 
resuspended in GAB or NMR Buffer according to the desired experiment. Actin quantification 
was performed by the precision red advanced protein assay reagent (Cytoskeleton, Catalog 
No.ADV02-A) as suggested by Cytoskeleton, Inc. Here the optical density of the conjugated 
actin was recorded at 600 nm (OD600) on a spectrophotometer (BioSpectrometer® kinetic, 
Eppendorf). The protein concentration was then estimated according to:  1.00 𝑂𝑂600 = 100 𝜇𝜇 protein per mL reagent per cm light path-length 
The measured absorbance was multiplied by 100 to achieve µg of protein per mL of the original 
sample. The procedure was repeated twice, one for determining the concentration of actin before 
polymerization and another time to estimate the efficiency of the polymerization process by 
determining the actin concentration in the supernatant after centrifugation. 
2.5.2. Human cofilin 
Human cofilin (Catalog No.CF01) was bought from Cytoskeleton Company. 100 µg of cofilin 
powder were resuspended in 20 µl of distilled water to have 5 mg/mL of protein in a final buffer 
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of 10 mM Tris pH 8.0, 10 mM NaCl, 5% sucrose and 1% dextran. The sample was subsequently 
dialyzed against GAB or NMR buffer to be used for electron microscopy or NMR experiments, 
respectively. For dialysis, a concentrator with a cutoff of 3 kDa (Amicon Ultra-0.5 mL 
Centrifugal filters) was used. 
2.6. F-actin binding assay 
For binding assays, NBD-conjugated actin from α-skeletal muscle was bought from Hypermol 
(www.hypermol.com). In this experiment, 7-chloro-4-nitrobenzeno-2-oxa-1,3-diazole (NBD)-
labeled G-actin was polymerized starting from 0.4 mg/ml of the conjugated actin. To provide 
stability to the filaments, the sample was supplemented with 10-fold excess of phalloidin 
(catalog no. P2141, Sigma-Aldrich). NBD-labeled actin was polymerized in presence of PB as 
explained before. Next, 0.25 µM of NBD-labeled F-actin was incubated with increasing amounts 
of Tau or Tau constructs. The change in fluorescence of NBD was followed in a Cary Eclipse 
fluorescence spectrophotometer (Agilent technology). Excitation and emission wavelengths were 
set to 480 and 530 nm, respectively. A total of three experiments were carried out at 25 °C in 
GAB and the standard deviation was estimated. The normalized decrease in fluorescence 
(equation 1) was analyzed and fitted by using equation 2 (Ojala, Paavilainen et al. 2002, Mattila, 
Quintero-Monzon et al. 2004): 
𝐸 = (𝐹−𝐹0)(𝐹𝑚𝑚𝑚−𝐹0)                                              (1) 
𝐸 = 1
2
𝐶 + 1
2
𝑍 −
1
2
�(𝐶 + 𝑍)2 − 4𝑍           (2)     
, where 
𝑍 = [𝑝𝑝𝑝𝑝𝑝𝑝𝑝][𝐹−𝑝𝑎𝑝𝑎𝑝]        and      𝐶 = 1 + 𝐾𝐾[𝐹−𝑝𝑎𝑝𝑎𝑝] 
A reference experiment with phalloidin-stabilized NBD-labeled F-actin in the absence of 
additional binding partners was performed, in order to control the stability of the filaments over 
the duration of the experiment. 
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2.7. Transmission electron microcopy 
Electron microscopy was performed by Gudrun Heim and Dr. Dietmar Riedel at the Facility for 
Transmission Electron Microscopy, Max Planck Institute for Biophysical Chemistry, Göttingen. 
Actin filaments were initially diluted to 10  µM in GAB. Samples were bound to a glow 
discharged carbon foil covered copper grid. After washing of the grids using ddH2O, the samples 
were stained using 1% uranyl acetate. Electron micrographs were recorded at room temperature 
using a CM 120 transmission electron microscope (FEI, Eindhoven, and The Netherlands) and a 
TemCam F416 CMOS camera (TVIPS, Gauting, Germany). 
2.8. Co-sedimentation assay 
In this experiment mixtures of F-actin with Tau (1:1 molar ratio) or Tau-peptides (1:10 
actin:Tau-peptide molar ratio) were incubated at room temperature for 30 minutes. In case of 
shorter peptides such as Tau(254-268), a 1:30 ratio was prepared. Centrifugation was performed 
in two separated steps in a Beckman Airfuge (rotor TLA 100.3). First a spin rate of 5000 g was 
used during 15 minutes, in order to collect bundles of F-actin (PB) at the bottom of the tube. The 
remaining sample was centrifuged at 100000 g during 1h for collecting actin filaments (PF). The 
final supernatant (SN) was also kept for later usage. Pellets were resuspended in 80 µl of GAB. 
For electron microscopy, 25 µl of sample were taken while the remaining 55 µl were loaded in a 
4-20% gradient SDS gel upon colored with Bromophenol Blue and denatured with SDS and 
heat. Polyacrylamide gels were treated with Coomassie (Brilliant) Blue to stain the proteins and 
later visualization on the Molecular Imager®(Gel Doc TM XR+; Biorad). 
2.9. MTSL-labeling of actin 
In order to perform PRE experiments, G-actin was labeled with MTSL ((1-oxy-2,2,5,5-
tetramethyl-d-pyrroline-3-methyl-methanethiosulfonate), Toronto Research Chemicals) on 
Cysteine-374 (C374). Directly before addition of MTSL, DTT was removed from the sample by 
using a 2 mL Zeba desalting column, which had been equilibrated with GAB at pH 6.8. Next, 
free sulfhydryl groups were modified by incubating the sample overnight at 0 °C with a 20-fold 
molar excess of MTSL. Unreacted MTSL was removed with another 2 ml Zeba desalting 
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column. Afterwards, MTSL-labeled actin was polymerized as described above, in order to obtain 
MTSL-labeled F-actin with the paramagnetic nitroxide tag covalently bound to C374.  
2.10. NMR spectroscopy 
2.10.1. One-dimensional NMR experiments 
In order to test protein integrity, one-dimensional (1D) experiments were performed before doing 
further experiments. To this end, a standard Bruker pulse sequence (zggpw19.pl) using a 3-9-19 
water gate for water suppression was used. Depending on protein concentration, a total of 64 or 
128 scans were recorded, while the time domain (TD) was set to 1k in all cases. The 3-9-19 
parameter D19, which takes into account the distance to the next excitation null, was set to 100 
µs. 
2.10.2. Saturation transfer difference (STD) 
Saturation transfer difference (STD) NMR is one of the most popular ligand-based NMR 
techniques for the study of protein-ligand interactions (Mayer and Meyer 1999, Viegas, Manso et 
al. 2011, Hetenyi, Hegedus et al. 2016, van Zundert, Rodrigues et al. 2016). This is a robust 
technique, which is focused on the signals of the ligand, without any need of processing NMR 
information about the receptor and only using small quantities of the unlabeled macromolecule. 
The method is based on the selective saturation of molecules with a high molecular weight such 
as microtubules and actin filaments. Subsequently the magnetization is transferred to the bound 
ligand, whose signals can be detected in a difference spectrum resulting from an on- and off 
resonance setup. A series of selective pulses was used to selectively saturate the protons of the 
receptor. At the same time, the receptor saturation frequency was applied at a proton frequency 
where no ligand resonances were observed. 
When the receptor is irradiated, magnetization rapidly spreads across the receptor by means of 
spin diffusion, which is then transferred to the protons of the ligand at the binding interface 
through a cross relaxation pathway. This principle is represented in Figure 2.2.  
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Figure 2.2. Schematic representation of STD NMR spectroscopy. 
Selective saturation transfer of magnetization from a protein to the binding region of the ligand. Protons 
from the ligand, which are in close proximity to the protein, will experience the STD effect (closed 
circles) while those which are far away from the binding site (open circle) will experience no STD effect. 
The intensity of the STD signal will depend on the proximity of the atom at the binding interface. 
2.10.2.1. Experimental procedure 
For STD-based NMR measurements, 800 µM of peptides were mixed with 26.6 µM F-actin in 
NMR buffer (molar ratio of 30:1). STD NMR spectra were acquired with and without F-actin to 
characterize the interaction. All STD spectra were recorded on a 700 MHz spectrometer 
equipped with a cryogenic NMR probehead. NMR spectra were acquired at 278 K using a series 
of 40 equally spaced 50 ms Gaussian-shaped pulses, in order to achieve saturation of protein 
NMR resonances for 2 seconds. Four different on-resonance irradiation frequencies were tested 
and -0.5 ppm was selected, to optimally achieve the protein saturation without ligand irradiation. 
The off-resonance frequency was set to 60 ppm in all cases. A total of 1024 scans were collected 
for each experiment with a recycle delay of 2 s. 
2.10.3. 2D NMR experiments 
2.10.3.1. Heteronuclear Single Quantum Coherence (HSQC) 
The Heteronuclear Single Quantum Coherence (HSQC) experiment is one of the most frequently 
used experiments in protein NMR spectroscopy. This method gives one peak per pair of coupled 
nuclei (I and X), whose two coordinates are chemical shifts of the two coupled atoms 
(Bodenhausen and Ruben 1980, McConkey BJ 2002).  
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Figure 2.3. Schematic representation of a 2D HSQC pulse sequence.  
An initial INEPT pulse train transfers polarization from 1H to 15N or 13C represented as X. The delay “τ” 
should be defined as 1/4J for the magnetization to be efficiently transferred to the X nucleous, where J is 
the coupling constant between 1H and X nuclei. φ1 an φrec reprsent a fase cicling for selecting a desired 
mgnetization pathway. Subsequently the antiphase magnetization evolves during the variable evolution t1 
period under the effect of X chemical shift. Heteronuclear 1H-X couplings are refocused by applying a 
180º 1H pulse at the middle of this period. A retro-INEPT pulse train converts X magnetization to in-
phase 1H magnetization. Proton acquisition is performed with X decoupling (DECOUPLE block). 
HSQC works by transferring magnetization from the “I” nucleus (usually the proton) to the “X” 
nucleus (usually 15N or 13C) using the Insensitive Nuclei Enhancement through Polarization 
Transfer (INEPT) pulse sequence. Because proton nuclei have greater equilibrium 
magnetization, the transfer process creates stronger signal on the second nucleus when compared 
to direct excitation of the “X” nucleus. In a second step, the magnetization evolves to be 
transferred back to the 1H nucleus for observation. The pulse sequence of the HSQC is 
schematically shown in Figure 2.3. An extra spin echo step can optionally be used to decouple 
the signal, simplifying the spectrum by collapsing multiplets into a single peak. For example, 
the 1H-15N HSQC detects correlations between 15N and 1H nuclei, which are separated by one 
bond. In proteins each residue, except prolines, has an amide proton attached to nitrogen in the 
peptide bond and the HSQC provides the correlation between the nitrogen and amide proton. 
Protein-protein and protein-ligand interactions can be well studied using the 2D 1H-15N HSQC 
experiment (Rajagopal, Waygood et al. 1997, O'Connell, Gamsjaeger et al. 2009). The binding 
effect can be correlated with changes in the chemical shift (δ) of the resonance and line 
broadening, because of changes in the chemical environment and appearance of additional 
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relaxation pathways in the binding region. To this end, a 2D 1H-15N-HSQC spectrum of 15N-
labeled protein will be recorded in the absence and presence of the unlabeled binding partner at 
stoichiometric or sub stoichiometric conditions. In case of the Tau/ F-actin interaction, the 
receptor (F-actin) is very large, interacting Tau residues experience extensive dipolar interaction 
and an increase in rotational correlation time, leading to severe line broadening. 
2D 1H-15N HSQC experiments were recorded on Bruker spectrometers (Bruker Karlsruhe, 
Germany) with 800 or 900 MHz proton frequency and equipped with a TCI cryogenic probe (Z-
gradient). A HSQC pulse sequence containing a 3-9-19 water gate for water suppression was 
used. The nitrogen carrier was set to 118 ppm and the spectral with was 24 ppm while for proton 
the carrier was set to the water resonance frequency. Spectra were acquired with 512 increments 
in the indirect dimension and 2k points in the direct dimension. For processing a zero filling of 
4k and 1k in the direct and indirect dimensions were used, respectively. A sine-squared bell 
window function shifted either by 90º or 60º was applied. Data were processed using NMRPipe 
(Delaglio, Grzesiek et al. 1995) and analyzed using the software Sparky 3.114 (T. D. Goddard 
and D. G. Kneller, http://www.cgl.ucsf.edu/home/sparky). 
2.10.3.2. Total Correlation Spectroscopy (TOCSY) 
Total Correlation Spectroscopy (also known as HOHAHA – HOmonuclear Hartmann HAhn) 
(Braunschweiler and Ernst 1983, Bax and Davis 1985, Nuzillard and Massiot 1991) is useful for 
dividing the proton signals into groups or coupling networks, especially when the multiplets have 
similar chemical shifts or there is extensive second order coupling (Cavanagh, Fairbrother et al. 
2007). A TOCSY spectrum yields correlations via spin-spin coupling through bond. TOCSY is 
often used in larger molecules with many separated coupling networks such as peptides, proteins 
and polysaccharides. In the TOCSY experiment, cross peaks are observed not only for nuclei, 
which are directly coupled, but also between nuclei which are connected through a chain of 
couplings. Therefore the TOCSY experiment is useful for identifying larger interconnected 
networks of coupled spins. Transfer of magnetization between multiple coupled spins is achieved 
by insertion of a repetitive sequence of radiofrequency pulses, resulting in isotropic mixing 
during the mixing period (Cavanagh, Fairbrother et al. 2007). In a TOCSY spectrum, cross peaks 
originate from protons of the same spin system. No magnetization transfer occurs between 
different residues, enabling identification of residue-specific spin systems (Wüthrich 1986).  
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2.10.3.3. Nuclear Overhauser Effect (NOE) 
The Nuclear Overhauser Effect is the most clear manifestation of the fact that two dipolar-
coupled nuclei do not relax independently (Cavanagh, Fairbrother et al. 2007). When a specific 
nucleus is magnetically excited and its neighbor is at equilibrium, relaxation occurs between the 
two nuclei. Because of this relaxation, intensities of the nucleus at equilibrium state changes. The 
smaller the physical distance between the nucleus at the equilibrium state and the excited 
nucleus, the bigger the expected change. NOESY cross-peaks are originated from the dipolar 
couplings resulting from interactions of spins through the space and hence only depend on the 
distance but not on the number of intervening bonds. The NOE is characterized by the cross-
relaxation rate constant (𝜎𝐼𝐼𝑁𝑁𝑁), where S and I refer to two different scalar-coupled spins. In 
general 𝜎𝐼𝐼𝑁𝑁𝑁 can be mathematically expressed as: 
𝜎𝐼𝐼
𝑁𝑁𝑁 = ℏ2𝜇02𝛾𝐼2𝛾𝑆2𝜏𝑐
40𝜋2𝑝𝐼𝑆
6 �−1 + 61+4𝜔02𝜏𝑐2�                    (3) 
, where ℏ is the Dirac constant, 𝜇0 is the magnetic permeability at vacuum, 𝛾 is the gyromagnetic 
ratio of the specific spin, 𝜏𝑎is the correlation time and 𝑟𝐼𝐼is the distance between I and S spins. 
In the extreme narrowing limit (i.e. 𝜔𝜏𝑎 << 1), the equation 3 is reduced to (Cavanagh, 
Fairbrother et al. 2007): 
𝜎𝐼𝐼
𝑁𝑁𝑁 = ℏ2𝜇02𝛾𝐼2𝛾𝑆2𝜏𝑐
8𝜋2𝑝𝐼𝑆
6                                                (4) 
Whereas in the spin diffusion limit (i.e. 𝜔𝜏𝑎 >> 1) 
𝜎𝐼𝐼
𝑁𝑁𝑁 = ℏ2𝜇02𝛾𝐼2𝛾𝑆2𝜏𝑐
40𝜋2𝑝𝐼𝑆
6                                                (5) 
equations 4 and 5 clearly reveal that the NOE is strongly dependent on the distance between the 
interacting spins. In practice a NOE cross peak can be observed only is the inter-spin distance is 
≤ 6Å.  
The pulse sequence for the Nuclear Overhauser Effect Spectroscopy (NOESY) experiment with 
a 3-9-19 water gate for water suppression is shown in Figure 2.4. Initially a π/2-t1-π/2 period 
frequency-labels the 1H spins and brings the magnetization back to “z” axis. Subsequently 
magnetization transfer occurs via dipolar coupling during a period τm. The proper selection of τm 
is crucial to determine the proper distances between the involved nuclei. Subsequently the 
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magnetization is rotated again by a π/2 pulse to be acquired previous suppression of the water 
signal by a 3-9-19 water-gate block. Upon acquisition, the system is let to reach the equilibrium 
during a delay d1. This delay should be around 6 times the longitudinal relaxation of the total 
system (T1).  
 
 
Figure 2.4. Schematic representation of a NOESY pulse sequence. 
The schema represents a phase-sensitive pulse sequence of a NOESY experiment “noesygpph19” from 
Bruker. The first three squeares on the button panel represent 90 degree pulses which are separated by a 
relaxation period (t1) where proton magnetization is rotated to the transversal plane. The mixing time (τm) 
period is required for the dipolar-mediated relaxation to occur. Other parameters like G1,2 and δ are 
required for a proper water suppression.   
2.10.4. Resonance assignment  
The unlabeled peptides Tau(211-242), Tau(254-268), Tau(254-284), Tau(254-290), Tau(292-
319) and Cib(D1) were assigned using two-dimensional 1H-1H TOCSY and 1H-1H NOESY 
spectra recorded at 278 K, either on Bruker 800 or 900 MHz spectrometer equipped with a 
cryogenic probeheads. Samples were prepared in NMR buffer at a concentration of 800 µM. 
Acquisition parameters were set to 40 transients, sweep widths of 12 x 12 ppm in the direct and 
indirect dimensions, respectively. The time domain (TD) was set to 2048 point in the F2 
dimension, while 512 points were used in F1. Mixing times of 70 ms for TOCSY and 80 ms for 
NOESY were used. Spectra were processed using NMRPipe (Delaglio, Grzesiek et al. 1995) and 
analyzed using the software Sparky 3.114 (T. D. Goddard and D. G. 
Kneller, http://www.cgl.ucsf.edu/home/sparky). The individual spin systems were identified by 
using TOCSY and were sequence specifically assigned in combination with NOESY (Wüthrich 
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1986). The assignments of hTau40 and K18 were performed previously in our lab (Mukrasch, 
Bibow et al. 2009) and were used to analyze the HSQC spectra. 
2.10.5. Transferred NOE (tr-NOE) 
The basic principle of transferred NOE (tr-NOE) was first described by Balaram, Bothner-By et 
al. (Balaram, Bothner-By et al. 1972) and reviewed by several other authors (Ni 1994, Post 
2003). The ideal systems for the observation of tr-NOE are those where interactions occur with 
dissociation constants within the μM to mM range, resulting in exchange of the ligand between 
the bound and free state, which is fast on the NMR time scale (Balaram, Bothner-By et al. 1972, 
Clore and Gronenborn 1982).  
For efficient magnetization transfer from the bound to the free state of the ligand, the following 
equation should be fulfilled: |𝑁𝑏 .𝜎𝑏| ≫ �𝑁𝑓 .𝜎𝑓� 
, where σ is the cross-relaxation rate and N the number of molecules in the free (Nf, σf) and 
bound (Nb, σb) states. 
 
Figure 2.5. Pictorial representation of a fast exchange ligand-receptor interaction. 
At the left panel the free ligand population (PfL) with its particular correlation time ( τc, fL). At the right 
panel part of the free ligands bind to the protein (PbL) acquiring a bigger correlation time (τc, fL) because 
they became part of the complex wit the protein for short time. Any change in conformation upon binding 
will be observed as the populated weighted averaging of the NMR observable NOE. 
For a successful experiment, special attention has to be addressed to the sample preparation. If 
the ligand-to-protein ratio is too high, there will be more ligand free in solution and, as a result, 
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its corresponding positive NOE may lead to a significant reduction or even cancelation of the tr-
NOESY enhancements coming from the negative NOE developed by the small fraction of bound 
ligand. On the other hand if the ligand-to-protein ratio is too low all the ligands will be in bound 
state and therefore the NMR signal would be too low. The cartoon representation of the tr-NOE 
concept is presented in Figure 2.5. 
As represented in Figure 2.5 the observation of tr-NOE relies on the existence τc for the free and 
bound ligand. Free ligands are usually low-to-medium molecular weight, which have short 
correlation times and no spin diffusion. Therefore they exhibit small positive NOEs. On the other 
hand, when a ligand is bound to a receptor (big protein), it acquires the motional properties of the 
macromolecule during the residence time in the bound state, thus exhibiting large correlation 
times τc, extensive spin diffusion, and strong negative NOEs (i.e. transferred NOEs). Spin 
diffusion, which are typical for large molecules, is one of the major drawbacks of this 
experiment. In order to minimize the diffusion effect, short mixing-times should be used. In 
addition, NOE buildup curves, in which the NOE intensity of cross-peaks is recorded as a 
function of mixing time, might provide evidence for spin diffusion (Williamson 2009).  
The tr-NOE cross peaks are finally treated as a normal NOE to derive distances restraints for 
later usage in structure determination. 
Tr-NOESY experiments for Tau peptides in the presence of F-actin were performed at 278 K, on 
Bruker 800 and 900 MHz spectrometers equipped with cryogenic probeheads. Samples were 
prepared in NMR buffer with a peptide concentration of 800 µM and 26.6 µM of F-actin in a 
30:1 ratio. 2D tr-NOESY experiments were carried out with 64 transients and a time domain of 
2040 data points for 512 increments. A sweep width of 12 x 12 ppm was set in both dimensions. 
A total of five different mixing times (50, 80, 100, 150 and 250 ms) were recorded, in order to 
determine a NOE buildup curve. The data were zero filled to 4096 x 1024 data points prior to 
Fourier transformation. Data were processed using Topspin 3.5pl5 and NMRPipe (Delaglio, 
Grzesiek et al. 1995), and analyzed using Spark 3.114 (T. D. Goddard and D. G. 
Kneller, http://www.cgl.ucsf.edu/home/sparky) . 
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2.10.6. Structure Calculation. 
Distance restraints were obtained from tr-NOESY contacts observed in 2D 1H-1H NOESY 
spectra acquired with 100 ms mixing time. A total of 200 conformers were calculated using the 
standard simulated annealing schedule with 10000 torsion angle dynamics steps per conformer 
using CYANA 3.97 (Rodriguez, Schaefer et al. 2003, Güntert and Buchner 2015). The intensities 
of manually assigned cross-peaks were calibrated using the automated calibration method 
“calibrate”, which is available for CYANA. This procedure converts NOESY cross-peak 
intensities into upper distance limits (UPL). There exists a functional relationship between the 
NOE peak intensity/ volume of NMR signal and the inter-proton distance, which is inversely 
proportional to the 6th power of the distance between protons. This can be mathematically 
expressed as: 
𝑉 = 𝐴
𝑑6
 
, where V is the peak volume (or intensity), d is the upper distance limit and A is a calibration 
constant. The script (Fortran format) used for CYANA calculation is presented in Table 2.2. 
All structures and distance restraints derived from CYANA were transformed to the XPLOR-
NIH input file format. Structures calculated by CYANA were subsequently refined in XPLOR-
NIH using a restrained simulated annealing (SA) protocol (Schwieters et al., 2003). During 
simulated annealing, the temperature was lowered from 500 K down to 100 K. To avoid 
potential miscalibration of NOE intensities, intra-residual NOEs were not considered. Lower and 
upper limits for short- and medium-range NOEs were set to 1.8 Å and 6.0 Å, respectively. 
Statistical knowledge-based potentials for 2D and 3D torsion angle correlations were used and 
their force constants were ramped during the refinement from 0.002 to 10. A total of 400 
structures were calculated and the 20 lowest-energy conformers were selected for analysis using 
the protein structure validation software suite (PSVS) (Bhattacharya, Tejero et al. 2007). 
Visualization was performed using PYMOL (The PyMOL Molecular Graphics System, Version 
1.5.0.4 Schrödinger, LLC) and MOLMOL (Koradi, Billeter et al. 1996) 
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Table 2.2. Script used for structure calculation with a simulated annealing algorithm.  
The script calculates 200 structures with 10000 annealing steps. 
name       := pept_bound 
peaks      := pept_bound                         # names of peak list(s)  
prot       := pept_bound                          # names of proton list(s) 
tolerance  := 0.02                        # shift tolerances: H, H' 
calibration:=                              # calibration constants, automatic if empty 
dref       := 4.2                         # average distance limit for automatic calibration 
if (master) then                           # execute the following commands only on master node 
# ---- check consistency of peak and chemical shift lists---- 
peakcheck peaks=$peaks prot=$prot        # check consistency of peak and shift       assignments 
 # ---- calibration ---- 
calibrationprot=$prot peaks=$peaks constant=$val('calibration') dref=$dref  # calibrate NOEs 
peaks calibrate "**" simple              # convert calibrated NOEs into distance restraints 
writeuplpept_bound-in.upl                     # write initial upper distance limit file 
distance modify                          # remove irrelevant restraints, apply pseudoatom corrections 
writeuplpept_bound.upl                        # write upper distance limit file 
 
2.11. Protein-protein docking 
Molecular docking can be used to model the interaction between a small molecule and a protein 
(McConkey BJ 2002). In principle docking can be achieved through two interrelated steps: first 
the conformations of the ligand in the active site are sampled, followed by ranking these 
conformations via a scoring function. Ideally, sampling algorithms should be able to reproduce 
the experimental binding mode and the scoring function should also rank it highest among all 
generated conformations. Docking efficiency will increase if binding sites are known in advance.  
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The 3D structure of the peptide Tau(254-290) and knowledge about its binding site in F-actin 
were used to dock Tau(254-290) to F-actin. Molecular docking was performed using the 
Haddock web server (van Zundert, Rodrigues et al. 2016). Here, the cofilin-decorated F-actin 
structure (PDB id 3J0S (Galkin, Orlova et al. 2011)) was modified to use only the F-actin 
structure. Furthermore, we restricted the binding area to the hydrophobic pocket of F-actin 
between two actin protomers, which is exposed to the solvent (Dominguez 2004). Two 
consecutive actin protomers were used in the calculations. Residues V45-G48 and Q49 form 
protomer “I” and residues L140, Y143, A144, G146, R147, E167, G168, G342, L346, S348, 
T351, Q354, M355 and V370-F375 from protomer “II” were defined as active residues, while 
the surrounding residues were defined as passive residues. HADDOCK clustered 192 structures 
in 4 clusters, which represent 96.0% of the water-refined models generated by HADDOCK. 
Conformations from the cluster with the highest HADDOCK-score were used for further 
analysis.  
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3. Results 
3.1. Interaction of Tau with G-actin 
The interaction between G-actin and Tau or Tau fragments was tested in two different ways. 
First the change in intensity of NBD-labeled actin in presence of increasing concentrations of 
ligands was analyzed and binding affinities were derived. Secondly, NMR-based experiments 
identified the Tau regions involved in the interaction with G-actin. In addition, Paramagnetic 
Relaxation Enhancement (PRE) as well as competition experiments provided information about 
the region through which G-actin recognizes Tau. 
3.1.1. Tau and Tau fragments bind to G-actin 
To determine of the binding affinity between G-actin and Tau or Tau fragments, the change in 
fluorescence intensity of 0.2 µM NBD-labeled G-actin in presence of increasing concentrations 
of ligand was registered. Prior to the experiment, LatB was added to the actin solution to prevent 
filament formation. As shown in Figure 3.1a and Figure 3.1b the mixture of Tau or K18 with 
NBD-labeled G-actin does not change the position of the peak even though the binding place is 
saturated. Moreover, addition of K18 decreased the fluorescence intensity in a 67 % while Tau 
does it in a 45%. Affinities of Tau(254-284) or its phosphorylated version Tau(254-284pS262) 
bound to G-actin were also calculated Figure 3.1. For better analyze the results the calculated 
affinities for full-length Tau (hTau40), K18, Tau(254-284) and Tau(254-284pS262) are 
presented as a histogram Figure 3.1c. Error bars represent the standard deviations of three 
different experiments. The experiments reveal that either hTau40 or Tau fragments bind to G-
actin with a high affinity. However, phosphorylation of Tau(254-284) on S262 decreased the 
affinity for binding to G-actin in one order of magnitude.  
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Figure 3.1. Fluorescence-based analysis of NBD-labeled G-actin bound to Tau and Tau constructs.  
The superposition of fluorescence emission spectra of NBD-labeled G-actin in presence of incrising 
concentrations of hTau40 or K18 is presented in (a) and (b) respectively. A dashed line labels the 
maximum of emission for both cases at 530 nm. (c) The dissociation constants for all the cases are plotted 
as a bar diagrams where error bars represent the standard deviation for three different experiments. The 
dissociation constants of hTau40 (d), K18 (e), Tau(254-284) (f) and Tau(254-284pS262) (g) were 
determined by the fitting of the experimental data to a single binding curve as explained in Materials and 
Methods section.  
3.1.2. Identification of binding regions of Tau in complex with G-actin 
The interaction between Tau and G-actin was probed by NMR spectroscopy to get insight into 
the regions of Tau that interact with actin. The analysis of the intensity peaks on a 1H-15N HSQC 
experiment from 15N-labeled hTau40 in absence or presence of LatB-treated G-actin provided a 
rally powerful way to distinguish the Tau binding hot spots. In this experiment 30 µM of G-actin 
were mixed with 300 µM LatB. After 30 minutes 15 µM of 15N-labeled hTau40 were added to 
the solution in a 1:2 ratio and a 1H-15N HSQC was recorded at 278 K. A second experiment was 
measured only with hTau40 supplemented with LatB to be used as reference. 
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The superposition of 1H-15N HSQC spectra from hTau40 in absence (gray) and presence of G-
actin (red) is ahown in Figure 3.2. The previous resonance assignment of hTau40 was used for 
the analysis (Mukrasch, Bibow et al. 2009). Residues with lower NMR signal intensity such as 
G365, G302 (top-right panel) and K311 or V309 (bottom-right panel) are those in close contact 
to G-actin. For better analyze the regions involved in binding an intensity plot was built for both 
free and bound Tau. NMR intensities were plotted against the number of residues (Figure 3.3).  
 
Figure 3.2. 2D 1H-15N-HSQC spectra of hTau40 in presence (red) and absence (grey) of G-actin.  
At the right panel selected regions are magnified for better observe some of the residues involved in 
binding. 
The non-uniform reduction in signal intensities in the spectrum of Tau bound to G-actin is 
caused by the exchange of Tau molecules between the free and bound states. The experiment 
revealed that the interacting regions of Tau in complex with G-actin comprise the proline-rich 
region (P1 and P2 top panel) and the repeat domain of hTau40 (R1-R4 top panel). Interestingly a 
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very specific region between inserts N1 and N2 and proline-rich region (top panel) from residue 
L114-T123 that corresponds to a transient α-helix on Tau (Mukrasch, Bibow et al. 2009) is also 
interacting with actin. According to the analysis the N-terminal part of Tau does not seems to be 
involved in binding to G-actin.  
 
Figure 3.3. Tau/G-actin interaction. 
NMR signal intensity ratio between signals observed in the 1H-15N HSQC spectra for hTau40 in presence 
and absence of two-fold excess of G-actin. Organization of Tau domains is shown at the top panel: N1 
and N2 represent the two inserts at the N-terminus, P1 and P2 the proline-rich regions and R1-R4 
correspond to the different repeats. 
 
Figure 3.4. Combined chemical shift perturbation of Tau bound G-actin from 1H-15N-HSQC.  
Organization of Tau domains is shown at the top panel. 
In addition the chemical shift perturbation (CSP) analysis revealed that the regions involved in 
binding are also showing perturbation in the chemical environment (Figure 3.4). Only the 
proline-rich and repeat regions show a binding effect as well as the region from L114-T123.  
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3.1.3. Tau fragments compete with Tau for binding to G-actin 
Upon identifying the Tau regions involved in binding competition experiments were performed 
between hTau40 and selected peptides from the identified binding hot spots. To this end, 
peptides Tau(211-242) form P2, Tau(254-290) from R1-R2 and Tau(292-319) from R2-R3 were 
synthesized. 
The competition experiment between hTau40 and Tau(211-242) for binding to G-actin was 
performed in a titration-based HSQC experiment. To do that, a solution containing of 15 µM of 
Tau and 30 µM G-actin (1:2 ratio) was prepared in NMR buffer. All the samples were previously 
supplemented with 30-fold excess of LatB to prevent actin polymerization. Two different 1H-15N 
HSQC experiments were acquired for Tau in absence and in presence of G-actin. Subsequently, 
the experiment was repeated twice upon adding 150 and 300 µM of Tau(211-242). An intensity 
plot from the 1H-15N HSQC spectra was built (Figure 3.5a) and the ratio between the bound Tau 
(Ibound) and the free form (Ifree) was compared. Interestingly, increasing amounts of peptide 
detaches the proline-rich and repeat regions of Tau from G-actin surface in a clear competitive 
manner.  
Similarly a competition experiments were performed between hTau40 and the peptides Tau(254-
290) and Tau(292-319). The analysis of the intensity plots (Figure 3.5b and Figure 3.5c) showed 
a similar competition profile as in case of Tau(211-242). 
The competition experiments suggest that all the peptides used in the analysis bind to the same 
place on G-actin and therefore addition of an excess of peptides detaches Tau from actin. 
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Figure 3.5. Competition experiments between Tau and Tau fragments for binding to G-actin. 
(a) 1H-15N HSQC intensity plots between Tau and Tau(211-242), Tau and Tau(254-290) (b), and 
Tau(292-319) (c). Organization of Tau domains is shown at the top of the three panels. 
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3.1.4. Mapping the binding of Tau on G-actin surface 
We have identified the regions of Tau that recognizes the G-actin molecule but where does Tau 
binds on G-actin surface?. To clarify this question competition experiment were performed with 
molecules with a known binding site on G-actin surface. These molecules are ciboulot (Cib) and 
the small molecule latrunculin B (LatB). Cib is a protein from the Thymosin-β4 family, which 
binds to G-actin with a stoichiometry of 1:1 and a dissociation constants of 2.5 ± 1 µM (Boquet, 
Boujemaa et al. 2000). Cib binds to the hydrophobic pocket of G-actin between subdomains 1 
and 3 (Dominguez 2004, Hertzog, van Heijenoort et al. 2004) as shown in Figure 3.7a. On the 
other hand LatB, derived from red sea sponges, binds to G-actin at the nucleotide-binding pocket 
between subdomains 2 and 4 (Figure 3.6a) with a stoichiometry of 1:1 avoiding the actin 
polymerization (Sasse, Kunze et al. 1998). 
3.1.4.1. Tau does not bind on the nucleotide-binding pocket of G-actin 
 
Figure 3.6. Tau does not compete with LatB for binding to G-actin on the nucleotide-binding 
pocket. 
Competition experiment between Tau and LatB for binding to G-actin. (a) Cartoon representation of G-
actin (pink) in complex with LatB (red) (PDB id 2Q0U (Allingham, Miles et al. 2007)). The four 
subdomains of G-actin are numbered. (b) Intensity plots derived from the 1H-15N-HSQC experiments 
where the intensity ratio between Tau bound to G-actin (Ibound) and in solution (Ifree) is plotted against the 
number of residues (grey). The binding profile in presence of LatB is shown in red. Organization of Tau 
domains is shown at the top panel. 
To determine whether Tau binds to the nucleotide binding of G-actin a competition experiment 
between hTau40 and LatB was performed. In this experiment the intensities of the 1H-15N HSQC 
spectrum when LatB is added to the Tau/G-actin complex for both the reference experiment (Tau 
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alone) and the complex (Tau/G-actin) were compared. Here, 20-fold excess of LatB was added 
to the complex in a 1:2:20 ratio and supplemented with 2% DMSO for solubilize the molecule.  
The intensity plot from the titration is shown in Figure 3.6b. The experiment revealed that there 
is no competition between Tau and LatB at this selected ratio meaning that Tau does not bind on 
the nucleotide-binding pocket of G-actin. 
3.1.4.2. Tau binds to the hydrophobic pocket of G-actin 
3.1.4.2.1. Competition experiment with Cib(D1) 
Similarly a competition experiment was performed with hTau40 and Cib(D1). Cib(D1) is the 
binding region of ciboulot that binds to G-actin and comprises the first 31 residues from the N-
terminal part of the full-length protein. The 3D structure of Cib(D1) in complex with G-actin is 
shown in Figure 3.7a. Previously before adding Cib(D1) the G-actin was incubated with 10-fold 
excess of LatB to prevent actin assembly. We discard any interaction between Cib and LatB 
because they have a different binding site on actin (Guo, Shillcock et al. 2010, Dominguez and 
Holmes 2011). As in case of LatB, a single-point titration experiment was performed where 20-
fold excess of Cib(D1) was added to the Tau/G-actin complex. For better analyze the 
experimental data from the 1H-15N HSQC spectra, the Tau sequence was divided in three 
different regions: Projection domain (PD), Proline-rich region (PR) and the repeat region (RR) as 
shown in Figure 3.7b. A bar diagram was constructed where the average intensities of the Tau/G-
actin complex in absence (grey bars) and in presence of 20-fold excess of ciboulot (blue bars) 
were compared Figure 3.7c. The interaction of Tau with monomeric actin decreased the average 
intensities of the PR and the RR but the addition of excess of ciboulot to the complex detached 
Tau from actin surface in a clear competitive manner. 
The competitions between Cib and Tau constructs were also tested using STD-NMR 
spectroscopy. The 1D STD-NMR method was used by saturating resonances on G-actin at -1 
ppm corresponding to the methyl proton region on G-actin. As a reference, a second 1D 
experiment was recorded by saturating the sample at 60 ppm, which is far from any proton 
resonance in the sample. The saturation of methyl protons in G-actin is first spread via spin 
diffusion to all G-actin protons. Subsequently the magnetization is transferred to the protons of 
the ligand via dipolar coupling whose transiently bind to G-actin. In this way, weak interactions 
between ligand and protein are detected and protons involved in the binding are identified. 
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Figure 3.7. Tau and ciboulot shares the binding site on G-actin surface. 
(a) Cartoon representation of G-actin (pink) in complex with Cib(D1) (blue light) from protein databank 
(PDB id 1SQK (Hertzog, van Heijenoort et al. 2004)). Actin molecule is subdivided on subdomains 1-4. 
(b) Domain distribution of Tau where three important regions are gihlighted as Projection domain (PD), 
Proline-rich region (PR) and Repeat region (RR). (c) The 1H-15N HSQC average intensity of the different 
regions of Tau represented in (b) are shown as a bar diagram were intensities of Tau in presence of G-
actin (grey bars) are compared to the intensities from ternary compex in presence of 20-fold excess of 
ciboulot (blue bars). 
For these experiments increasing concentrations of Cib(D1) were added to a mixture containing 
G-actin and 60-fold excess of Tau peptides. The analysis of the STD spectrum revealed that 
some of the peaks form the peptide Tau(254-290) (see grey arrow on Figure 3.8a) strongly 
decreased with the addition of Cib(D1). This means that Cib(D1) competes with this peptide for 
binding to G-actin, a finding that correlates with the observation in Figure 3.7b. Other regions of 
the spectrum cannot be analyzed because of the overlap with the signals coming from Cib(D1). If 
the same experiment is performed but in presence of two peptides from P1 and P2 regions such 
as Tau(161-188) and Tau(211-242) respectively, the analysis is not feasible because of the 
overlap between signals form peptides and Cib (Figure 3.8b and Figure 3.8c). Nevertheless 
competition between Cib and these two Tau peptides cannot be discarded. 
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Figure 3.8. STD-based competition experiment between Cib and Tau fragments for binding to G-
actin.  
(a) Competition experiment between Tau(254-290) and Cib for binding to G-actin. Gray arrows label 
residues from the peptide showing a competition effect upon adding Cib. (b) Competition experiment 
between Tau(161-188) and Cib for binding to G-actin. (c) Competition experiment between Tau(211-242) 
and Cib for binding to G-actin. 
  
 
Results 
 
  
56 
3.1.4.2.2. Further evidences form the binding of Tau on the hydrophobic pocket of G-
actin 
To further analyze whether Tau binds on the hydrophobic pocket of G-actin we used the effect of 
paramagnetic centers on NMR resonances. Particularly useful are paramagnetic nitroxide tags 
such as MTSL, which can be attached to cysteine residues in proteins. The attachment of MTSL 
to the protein causes an enhanced relaxation of protons, which are less than ~25 Å from the 
paramagnetic center (Gillespie and Shortle 1997). We thus sought a way to attach MTSL to a 
single cysteine in actin. Actin in total contains six cysteine residues. However, only the C-
terminal C374 is exposed to the solvent (Figure 3.9a) (Yasunaga and Wakabayashi 2001). Tau 
was then mixed with two-fold excess of MTSL-labeled G-actin in a 1:2 ratio (G-actin in excess). 
The 1H-15N HSQC spectra of both paramagnetic and diamagnetic states of actin were acquired. 
The superimposed spectra in absence (red) and presence (black) of the paramagnetic tag are 
shown in Figure 3.9b.  
Subsequently a single residue analysis was performed taking the ratio between the paramagnetic 
(Ipara) and diamagnetic (Idia) contributions as represented by the black line on Figure 3.9c). When 
diamagnetic and paramagnetic contributions are compared, residues in close contact with MTSL 
experience an enhanced relaxation because of the dipolar interaction. The PRE profile contained 
eight peaks corresponding to residues L243-K280, N286-K298, G301-K311, V318-G333 and 
Q351-T361. Interestingly these regions comprise the four KXGS motifs of Tau (red arrows) as 
well as the two hexapeptides 275VQIINK280 and 306VQIYK311 (green arrows) (Figure 3.9c,d), 
which are related to Tau aggregation in Alzheimer’s disease (von Bergen, Friedhoff et al. 2000).  
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Figure 3.9. The PRE approach reveals that Tau binds nearby the hydrophobic pocket of G-Actin. 
(a), MTSL tagging on C374 from native G-actin (pink) (PDB id 3HBT (Wang, Robinson et al. 2010)) 
where diferent subdomains of actin are numbered. (b) Superimposed 1H-15N-HSQC spectra in presence 
(black) and absence (red) of MTSL are presented while peaks from some residues are labeled. (c), The 
plot represents the intensity ratio between a sample containing Tau and MTSL-labeled G-actin (Ipara) and 
its diamagnetic version (Idia). Red arrows highlight those regions where KXGS motifs are present while 
the green ones correspond to the two hexapeptides of Tau. Organization of tau domains is shown at the 
top panel. (d) Amino acid sequence of full-length Tau. Grey bars comprise the most afected residues 
above the dashed line in (c). KXGS morifs are colored in red while hexapeptides are in green. 
3.2. Interaction of Tau with F-actin 
Several authors have reported the interaction between Tau and F-actin by using different in vivo 
and in vitro assays (Biernat and Mandelkow 1999, Yu and Rasenick 2006, Spears, Furgerson et 
al. 2014). Tau was found to interact with F-actin in Drosophila neurons promoting the F-actin 
bundle formation (Fulga, Elson-Schwab et al. 2007) where the presence of Tau increased the F-
actin stability while G-actin levels remained unaffected. In the same study an in vitro assay 
showed that Tau enhance the F-actin stability even in presence of swinholide-A, an F-actin 
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depolymerizing agent. Nevertheless the nature of this interaction as well as the interacting 
regions on Tau and F-actin are still unclear. Therefore we decide to study this interaction by 
using NMR as well as other biophysical techniques. 
3.2.1. Tau interacts with and promotes the bundles of actin filaments 
The interaction between Tau and F-actin was tested by means of EM. To do so, a 20 µl solution 
of equimolar ratio of F-actin and Tau were prepared in GAB. According to the EM pictures 
(Figure 3.10a), the addition of Tau to the F-actin solution promoted F-actin bundles (closed 
arrowheads). EM pictures revealed that the bundling was not 100% efficient and still some single 
filaments (open arrowheads) are observed in the background. The diameters of these filaments 
are in the range of 7 nm which in agreement with the literature (Egelman 1985, Egelman 2003). 
Bundles with diameters ranging between 20 and 150 nm are observed. 
 
Figure 3.10. Negatively stained electron micrograph from Tau-promoted F-actin bundles. 
(a), Tau interacts with F-actin and promotes bundles formation at low ionic strength as seen by electron 
microscopy. In the figure single filaments as well as F-actin bundles are labeled with open and closed 
arrowheads respectively. Magnification bar correspond to 150 nm. (b) The interaction was also analyzed 
by SDS polyacrylamide gel. Here the previously treated samples by co-sedimentation assay were loaded 
in a 4-20% gradient gel. A sample containing only Tau-promoted bundles of F-actin was loaded in lane 
PB while individual filaments were loaded on lane PF. The final supernatant containing only G-actin and 
Tau were loaded in lane SN. Open and closed arrowheads represent a molecular weight corresponding to 
Tau and actin respectively. 
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Co-sedimentation assay provided further support for the Tau-promoted bundles. In this 
experiment the same sample was differentially centrifuged as explained in material and methods. 
Pellets were reconstituted in 80 µl GAB supplemented with 10mM NaCl and denatured with 
Loading Buffer Blue (2X). Afterwards, aliquots form supernatant (SN), filament (PF) and 
bundles (PB) fractions were loaded in a 4-20% gradient gel as shown in Figure 3.10b. According 
to the gel quantification a 63 % of Tau and 49 % actin remains in the supernatant meaning that 
the polymerization of actin was not 100% efficient. Only an 8 % of Tau molecules are bound to a 
3% of single filaments. This observation is in agreement with what we so by EM where still is 
possible to observe single filament at the background. On the other hand the other 29 % of Tau 
appears to be cross-linking F-actin as seen in lane PB. These results confirm that Tau is able to 
interact with F-actin and promote the bundle formation, a finding that has been broadly boarded 
in literature.  
3.2.2. NBD-fluorescence reveals strong binding between Tau and F-actin 
In order to gain insight into the affinity of the Tau/F-actin-interaction, the change in fluorescence 
of 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD)-labeled F-actin upon addition of Tau was 
followed. 0.2 μM of NBD-labeled and phalloidin-stabilized F-actin were mixed with increasing 
amounts of Tau. The addition of Tau up to saturation decreased the NBD-fluorescence in 85 % 
as shown in Figure 3.11a almost twice that in presence of G-actin. The experiment was repeated 
three times and the errors are reported. A fit to the experimental data using a single binding site 
model resulted in a dissociation constant of 60 ± 10 nM (Figure 3.11b). Other stoichiometries, 
however, cannot be excluded. The derived dissociation constant is lower than a previously 
reported value of 241 ± 43 nM (Elie, Prezel et al. 2015). This is likely because of differences in 
ionic strength, because previous studies used phosphate buffer (Elie, Prezel et al. 2015), while 
we chose general actin buffer. 
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Figure 3.11. NBD-fluorescence reveals a strong binding between Tau and F-actin. 
The superposition of the fluorescence emission spectra of NBD-labeled F-actin in presence of increasing 
concentrations of hTau40 is showed in (a). A dashed line represents the maximum of emission around 
530 nm. (b) The dissociation constant of hTau40 was determined by the fitting of the experimental data to 
a single binding curve as explained in Materials and Methods section. 
3.2.3. Identification of binding regions of Tau in complex with F-actin 
In order to identify residues in Tau that bind to F-actin, we used NMR spectroscopy. F-actin 
and 15N-labeled Tau were mixed in a 2:1 molar ratio and a two-dimensional 1H-15N HSQC 
experiment was recorded. Comparison with a reference spectrum of Tau alone showed that 
addition of F-actin into the Tau pool decreased the signal intensity of several Tau residues 
(Figure 3.12). Very little chemical shift changes were observed, indicating that the binding 
process is intermediate to slow on the NMR time scale. According to the resonance assignment 
of Tau (Mukrasch, Bibow et al. 2009), cross-peaks from residues such as S262, N265 and T319 
were strongly attenuated. Other residues including T175 and T217 were less affected, and S46 
and S64 were not perturbed at all.  
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Figure 3.12. Superposition of 1H-15N HSQC spectra of hTau40 in absence (gray) and presence 
(blue) of F-actin. 
 
Figure 3.13. Residue-specific changes in 1H-15N HSQC signal intensities of Tau upon addition of F-
actin.  
Ifree and Ibound are intensities in the absence and presence of a two-fold excess of F-actin. Organization of 
Tau domains is shown at the top panel. 
Figure 3.13 highlights the sequence specific intensity ratio of all non-overlapping cross-peaks of 
Tau in the presence and absence of F-actin. Low (1-Ibound/Ifree) values are expected for residues 
that do not directly bind to F-actin. In contrast, residues, which are bound to F-actin, should have 
large (1-Ibound/Ifree) values, because their resonances would – due to the high molecular weight of 
the complex – no longer be observable by solution-state NMR. The analysis reveals that the 
proline-rich regions P1-P2 and the four pseudo-repeats contribute to the Tau/F-actin interaction. 
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The strongest NMR signal attenuation was observed for K254-V287, K294-K331 and E342-
D358, suggesting that these Tau residues have the highest affinity towards F-actin. 
3.2.4. Short Tau fragments from the MBD also promote F-actin bundles 
formation 
To directly prove the effect of short regions of Tau on the binding a Tau fragment ranging from 
K254 to K290 (Tau(254-290)) was synthesized. Then 10 µM of F-actin were incubated with a 
10-fold excess of Tau(254-290) in GAB and taken to EM. Interestingly Tau(254-290) also 
promoted F-actin bundles (Figure 3.14a) but still some single filaments are remaining at the 
background. Unlike hTau40, the bundles are less populated having a maximum diameter of 
around 60 nm. Similarly other Tau constructs located in the MBD like K18, which comprises the 
repeats from R1 to R4 and Tau(292-319), were also tested by EM. Both Tau fragments showed 
bundling effect on F-actin as well (Figure 3.14c and Figure 3.14b) although the effect is more 
dramatic in case of K18. However when a shorter peptide like Tau(254-268) is used no bundles 
effect is observed Figure 3.14d. This result is not surprising if we consider that the cross-linking 
effect of Tau is strongly dependent on the number of residues involved in binding as reported by 
Elie, Prezel et al. (Elie, Prezel et al. 2015). 
The affinities of Tau peptides like K18, Tau(254-284) and its phosphorylated version were also 
tested following the change in intensity of NBD at low ionic stress. A decrease in fluorescence 
upon addition of partner was observed for all the cases. We determined that K18 binds to F-actin 
with an affinity of 110 ± 1nM reducing the intensity of NBD in a 46 %. On the other hand 
Tau(254-284) binds to F-actin with a lower affinity (0.630 ±0.08 µM) while the intensity 
decreases only a 30 %. Surprisingly, when this peptide is phosphorylated on S262 its affinity is a 
bit lower that the wild type but still remains in the same order of magnitude (Kd = 0.95± 0.04 
µM). For better analyze the differences in affinities a bar diagram was made as shown in Figure 
3.15.  
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Figure 3.14. Electron micrographs from F-actin in complex with Tau peptides. 
(a) 10-fold excess of Tau(254-290) promotes bundles of F-actin. A similar effect can be observed when 
Tau(292-319) is used (b). (c) A longer Tau construct comprising the MBD (K18) has even a more 
dramatic effect. However a 30-fold excess of a shorter construct like Tau(254-268) does not promote the 
bundle formation (d). Magnification bars correspond to 150 nm in all the pictures. 
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Figure 3.15. Affinities of Tau and different Tau constructs for binding to NBD-labeled F-actin. 
The plot represents the calculated affinities based on the cahnge in intensity of NBD-labeled F-actin 
promoted by Tau or Tau constructs. The experiment was performed at low ionic stress and at 25 °C.  
Error bars represent the standard deviation from three different experiments for every sample. 
3.2.5. Tau binds to the hydrophobic pocket of F-actin 
In order to gain insight into how Tau regulates the polymerization and structure of F-actin, we 
sought to obtain information about the Tau-binding site on F-actin. X-ray crystallography and 
electron microscopy showed that several actin-binding proteins bind to a hydrophobic pocket 
between subdomains 1 and 3 of G-actin (Carlier and Pantaloni 1997). One of these binding 
partners is cofilin, a 21 kDa eukaryotic protein, which binds to F-actin with a Kd < 0.05 μM 
(Bobkov, Muhlrad et al. 2002) and results in disassembly of F-actin (Yonezawa, Nishida et al. 
1987, Suarez, Roland et al. 2011). Cryo-electron microscopy further showed that the binding site 
of cofilin on F-actin is highly similar to its binding site on G-actin (Figure 3.16a) (Carlier and 
Pantaloni 1997). To test if the binding site of Tau on F-actin overlaps with that of cofilin, we 
added a 10-fold excess of cofilin to a solution containing 15N-labeled Tau and 1.5-fold excess 
(with respect to Tau) of F-actin. For the resulting mixture, a 1H-15N NMR correlation spectrum 
was recorded. After addition of cofilin, Tau’s NMR resonance intensities and positions were 
similar to those in the absence of F-actin (Figure 3.16b), indicating that (i) Tau is no longer 
bound to F-actin and (ii) cofilin does not bind to Tau.  
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Figure 3.16. Tau competes with cofilin for binding to F-actin. 
(a) Cofilin (blue) binds to and decorates actin filament (pink) severing F-actin at the junction between 
undecorated and cofilin-decorated regions of F-actin (PDB id 3J0S (Galkin, Orlova et al. 2011)). (b) 
Influence of a 10-fold excess of cofilin on 1H-15N cross-peak intensities of Tau in presence of F-actin 
(Tau/F-actin molar ratio of 1:1.5). Normalized signal intensities in the absence (blue) and presence of 
cofilin (grey) are shown. 
 
Figure 3.17. SDS gel-based competition effect between Tau and cofilin for binding to F-actin. 
Centrifugation-based sedimentation of F-actin, F-actin+Tau (1.5:1) and F-actin+Tau+cofilin (molar ratio 
1.5:1:10). Supernatants (SN) and pellets (PF) were loaded in different lanes of a 4-20 % SDS gradient gel. 
Arrowheads from top to the bottom represent Tau, actin and cofilin bands, respectively. 
To further support a competition between Tau and cofilin for binding to F-actin, we repeated the 
F-actin/Tau co-sedimentation assay in the presence of Cofilin (Figure 3.17). The ImageJ-based 
gel quantification showed that the 41% of Tau molecules appears to be bound to F-actin while 
the remaining 59% of Tau is still in the supernatant. On the other hand when cofilin is added to 
the solution only the 6.5 % of Tau remains bound to actin because 35.5% of the total cofilin is 
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bound to F-actin in a competitive manner. In agreement with the NMR data, addition of cofilin 
decreased the amount of Tau that co-precipitated with F-actin. 
The cofilin-induced release of Tau from actin filaments might be caused by structural changes in 
actin upon binding of cofilin. Alternatively, cofilin and Tau share a common binding site, such 
that an excess of cofilin competes with the binding of Tau to actin. To distinguish between these 
two alternatives, we thus sought a way to attach MTSL to C374 in actin. C374 is in close 
proximity to actin’s hydrophobic pocket, where cofilin binds (Figure 3.16a and Figure 3.18a). 
We thus incubated G-actin with MTSL, followed by polymerization of the MTSL-tagged protein 
into F-actin. Subsequently, 15N-labelled Tau protein was added to reach a molar ratio of 1:2 (F-
actin in excess) and a 1H-15N HSQC of Tau was recorded. Comparison with the Tau spectrum 
recorded in the presence of diamagnetic F-actin revealed a specific paramagnetic relaxation 
enhancement (PRE) profile (Figure 3.18b). The PRE profile contained seven peaks 
corresponding to residues L243-A246, K259-K267, V275-L284, S289-S293, S305-V313, S320-
H330 and K375-F378. Thus, these Tau residues come within 25 Å of the paramagnetic center at 
C347 upon binding to F-actin. 
  
Figure 3.18. The PRE approach reveals that Tau binds nearby the hydrophobic pocket of F-actin. 
(a) Every protomer on F-actin was covalently MTSL-labeled on C374. The figure is based on the 
cryoEM-based 3D structure of F-actin (PDB id 3J0S (Galkin, Orlova et al. 2011)) where cofilin was 
removed. (b) Sequence-specific paramagnetic broadening induced in Tau by C374-MTSL-tagged F-actin 
(grey line). Ipara and Idia are signal intensities observed for individual cross-peaks in two-dimensional 1H-
15N HSQCs of Tau in the presence of a two-fold excess of paramagnetic and diagmagnetic F-actin, 
respectively. For comparison, the attenuation of Tau signals by diamagnetic F-actin is shown (blue bars). 
Observation of PRE broadening at the chemical shift of unbound Tau demonstrates that the Tau 
molecule exchanges between the F-actin-bound and free states. Because of the simultaneous 
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observation of line broadening upon addition of diamagnetic F-actin (Figure 3.12 and Figure 
3.18b), the exchange process is intermediate on the NMR chemical shift time scale. In addition 
to the specific PRE effects within and close to the repeat domain, a gradually increasing PRE 
effect was observed from approximately residue 170 towards the N-terminus. Because this 
region showed less sequence specific variation, we suggest that the broadening effect is the result 
of unspecific binding of the N-terminal half of Tau to the surface of F-actin. In addition, there 
might be contributions from paramagnetic broadening, when individual actin filaments come 
together in bundles. Notably, no PRE effect was observed at the C-terminus. 
3.2.6. Tau-F-actin interaction is mainly hydrophobic  
 
Figure 3.19. Salt titration experiment of Tau in presence of two-fold excess of F-actin. 
(a), Superposition of 1H-15N-HSQC intensity ratios between Tau bound to F-actin (Ibound) and free in 
solution (Ifree) as a function of the NaCl concentration. Organization of Tau domains is shown at the top. 
(b), sequence alignment of microtubule-binding repeats performed by Clustal Omega 1.2.3 
(http://www.ebi.ac.uk/Tools/msa/clustalo) 
 
To further analyze the nature of the binding between Tau and F-actin a titration experiment with 
different salt concentrations was performed. In this experiment the change of intensity a 1H-15N 
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HSQC experiment from mixtures of Tau and two-fold excess of F-actin was analyzed as a 
function of NaCl concentration Figure 3.19a. The analysis revealed that the affinity of Tau 
decreases with the increase of the salt concentration because of the ionic stress. Nevertheless, hot 
spots from the MBD are still bound to F-actin at higher salt concentrations most probably due to 
the presence of hydrophobic interactions. If the sequences of different repeats are compared 
(Figure 3.19b) the high sequence similarity and the presence of several hydrophobic amio acids 
explain the hydrophobic nature of the interaction even at high ionic stress. 
3.2.7. Tau phosphorylation affects the interaction between Tau and F-
actin 
Phosphorylation of Tau at S262 attenuates the Tau/F-actin interaction Tau protein is post-
transnationally modified by phosphorylation, acetylation and several other modifications 
(Morishima and Ihara 1994, Wang, Grundke-Iqbal et al. 1996, Yuzwa, Shan et al. 2012, Tracy, 
Sohn et al. 2016). An important class of kinases that phosphorylate Tau at S262 and the other 
KXGS motifs in the repeat domain are the microtubule-associated protein/microtubule affinity-
regulating kinases (MARKs) (Drewes, Ebneth et al. 1997, Yoshida and Goedert 2012, Schwalbe, 
Biernat et al. 2013). We phosphorylated full-length 15N-labeled Tau by MARK2, followed by 
NMR measurements in the absence and presence of F-actin. In contrast to the wild-type protein, 
little perturbation of the NMR signals in vicinity of the phosphorylation sites was detected 
(Figure 3.20). Residues such as S262 and S356 largely retained the NMR signal intensity in the 
presence of F-actin. However, residues in the proline-rich region, as well as in the segments 
V275-L284 and K294-V300, which do not contain MARK2-phosphorylation sites (Figure 
3.20c), were broadened in presence of F-actin. In agreement with these results, attachment of a 
phosphate group to S262 in the peptide Tau(254-284) decreased the affinity of the peptide for F-
actin (Figure 3.15).  
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Figure 3.20. MARK2 phosphorylation decreases Tau’s affinity for F-actin. 
(a) Selected region from a 1H-15N correlation spectrum of MARK2-phosphorylated Tau in the absence 
(gray) and presence of F-actin (orange; Tau/F-actin molar ratio of 1:1.5). (b) Selected region from a 1H-
15N correlation spectrum of wild-type Tau in the absence (gray) and presence of F-actin (blue; Tau/F-actin 
molar ratio of 1:1.5). (c) NMR signal broadening induced by F-actin in wild-type (blue bars) and 
MARK2-phosphorylated Tau (orange line). Tau residues phosphorylated by MARK2 are highlighted. 
To further investigate the phosphorylation effect of Tau on F-actin, the extents of actin bundles 
promoted by Tau(254-284) and its phosphorylated version Tau(254-284pS262) were compared. 
In this experiment a 10-fold excess of peptide added to F-actin and loaded in a 4-20% gradient 
gel after 30 minutes incubation (Figure 3.21). According to the gel quantification the 70% of F-
actin was bundled by Tau(254-284) while the other 25% remains as single filaments. If Tau(254-
284pS262) is used only 7% of actin is in bundles while 75% of actin remains as single filament. 
In agreement with Figure 3.15 the result clearly suggests that the phosphorylation of Tau(254-
284) on S262 decreases the bundling effect. This further support the effect in the intensity plot 
on Figure 3.20d were S262 appears to be detached from F-actin surface.  
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Figure 3.21. SDS-PAGE of phosphorylated and unphosphorylated Tau(254-284) in presence of F-
actin. 
Phosphorylation of S262 decreases the ability of Tau(254-284) to bundle F-actin. The arrowhead 
indicates the location of actin on the SDS gel. 
3.3. NMR-based structure calculation of Tau in complex with F-
actin 
So far we have shown that Tau binds to F-actin with a high affinity by means of the MBD and 
P2. We have also seen, by means of competition experiments that it binds on the hydrophobic 
pocket of actin, which is exposed to the solvent in the filament conformation. This interaction is 
very important for the Tau-promoted bundles stability that has been previously described (Fulga, 
Elson-Schwab et al. 2007). Provided that Tau is disordered in solution it is important to 
understand the mechanism involved in F-actin stabilization. Intrinsically disordered proteins 
often contain multiple binding sites with each binding site only providing low affinity for a target 
protein. In case of F-actin, the high molecular weight of actin filaments further complicates 
structural analysis of the complex between actin filaments and MAPs. 
Using a combination of NMR spectroscopy and other biophysical methods, we here dissect the 
regions in both Tau and F-actin that are important for complex formation. We then provide high-
resolution information about the structural changes that occur when Tau binds to F-actin and 
show that conformational changes in specific regions, which are separated by flexible linkers, are 
responsible for bundling of actin filaments as well as for cross-linking of actin filaments with 
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microtubules. Our results thus clarify the nature of interaction between actin and MAPs and the 
actin/microtubule crosstalk. 
3.3.1. Selection of Tau peptides 
While analyzing the intensity plots for Tau and F-actin interaction it is clear that linear motives 
of Tau are more affected than others. These linear motives are also connected by flexible linkers 
where the binding seems to be weaker. This allowed us to use the so-called “divided and conquer 
strategy” which consist in taking shorter fragments of Tau to derive the structure of full-length 
Tau in bound state to F-actin. Based on this idea the peptides Tau(254-290), Tau(292-319) and 
an even shorter peptide Tau(254-268) were taken to determine their 3D structures.  
 
Figure 3.22. Tau(254-290) bind to F-actin in a fast exchange regime.  
Selected region of 1D STD NMR spectrum of Tau(254-290) in presence of F-actin with a selective 
saturation of F-actin at 1 ppm (blue). The 1D spectrum from the sample is also show (red). Some of the 
affected protons from the peptide upon selective saturation are labeled. 
To determine whether these peptides are candidates for NMR-based structure determination, 
STD NMR experiments were performed. The efficacy of the STD method depend on the weak 
strength of the binding between molecules resulting in fast exchange regime between bound and 
free states of the ligands (Mayer and Meyer 1999). The STD NMR spectrum of Tau(54-290) 
bound to F-actin is shown in Figure 3.22. The appearance of STD peaks reveals that the peptide 
is bound to F-actin and the exchange is fast enough to detect transferred NOE peaks. Similarly 
other peptides used for structure calculation where also tested. 
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3.3.2. Peptides assignment 
The primary requirement of the NMR-based structure determination is the complete resonance 
assignment of the spectra. The resonance assignment of the spectra was done using the standard 
Wüthrich method, which was explained on section 2.10.4, for all the peptides analyzed in this 
work. The sequential connectivity form ith residue to i+1th residue was in the TOCSY spectra 
were performed with a help of NOESY spectra as can be seen on Figure 3.23 for Tau(254-290) 
(panel a) and Tau(292-319) (panel b). In the figure only few resonances and their respective 
connections are shown for clarity. Thus the complete resonance assignments of individual amino 
acids of Tau(254-268), Tau(254-290) and Tau(292-319) were performed unambiguously. 
 
Figure 3.23. Resonance assignment of Tau peptides. 
The resonance assignment of the peptides Tau(254-290) and Tau(292-19) are presented in (a) and (b) 
respectively. In both cases the assignment was performed by following the sequential connection (dashed 
lines) between residues is a TOCSY spectra (blue) with the help of a NOESY spectrum (red). Only some 
residues and their respective connections are shown for clarity. 
3.3.3. Structure calculation of Tau(254-268) bound to F-actin 
In order to derive the 3D structures of Tau(254-268) in bound state to F-actin, we used the so-
called transferred NOE approach which have been widely used to determine the structure of 
small ligands in complexes with high molecular weight binding partners (Andrianantoandro and 
Pollard 2006, Kadavath, Jaremko et al. 2015). To do so, two-dimensional Nuclear Overhauser 
Effect (NOE) spectra of Tau peptide in the absence and presence of F-actin were acquired to a 
sample containing a 30:1 molar ratio (peptide in excess) with 100 ms mixing time. Two different 
  
 
Results 
 
  
73 
regions of the superposition of the two spectra in absence (blue) and presence (red) of F-actin are 
showed in Figure 3.24. In both cases NOE peaks appeared because of the transferred 
magnetization from peptide in bound to free state upon addition of F-actin. These additional 
peaks in the complex are a consequence of the medium-range interactions (1<|i-j|≤4) as a result 
of the conformational change of the peptide bound to F-actin. When the peptide is free in 
solution its structure is disordered and only sequential and intra residue NOES are visible. 
 
Figure 3.24. Superimposed NOE spectra from Tau(254-268) in absence (blue) and in presence (red) 
of F-actin. 
New NOE peaks appear when F-actin is present because of the conformational change of the peptide 
upon binding.  
The analysis of the tr-NOEs indicates the presence of a number of medium-range interactions 
between almost all the residues when the peptide is bound to F-actin. However, only intra and 
sequential NOEs are observed when the peptide is in solution. The appearance or new cross 
peaks reveals the presence of a structured conformation of the peptide induced by the binding. 
Upon analyzing the full spectrum 313 distance restraints were collected as can be seen in Table 
3.1. Among these distances restraints 132 were intra residue, 143 sequential and 38 medium 
range interactions. 
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Table 3.1. Structural statistics of Tau(254-268) bound to F-actin 
Structural statistics for 20 final conformers of Tau (254-268) bound to F-actin 
Number of restraints 
     Intra residue NOE (|i-j|=0) 
     Sequential NOE (|i-j|=1) 
     Medium range NOE (<1|i-j|≤4) 
     NOE violations > 0.5 Å/structure 
Ramachandran plot statistics 
     Residues in most favored regions 
     Residues in additionally allowed regions 
     Residues in generously allowed regions 
     Residues in disallowed regions 
RMSD from the average structure 
     Backbone atoms 
     Full peptide 
     Heavy atoms 
313 
132 
143 
38 
0 
 
82.1% 
10.4% 
5.4% 
2.1% 
 
 
0.99 Å  
1.62 Å 
 
The initial structure calculations of Tau(254-268) were performed with Cyana 3.97 using 
distances restraints derived from Tr-NOESY experiment. Subsequently the structure was refined 
using XPLOR-NIH using the standard simulated annealing protocol. In order to avoid potential 
miscalibration of NOE intensities, only medium range NOE contacts were used. Lower and 
upper limits were set to 1.8 Å and 6.0 Å respectively. 400 structures were calculated and the 20 
lowest-energy conformers were selected for analysis using the protein structure validation 
software suite (PSVS) (Bhattacharya, Tejero et al. 2007). No violations above 0.5 Å were 
observed in these structures. Statistic from Ramachandran plot as well as the RMSD from the 
average structure reveals that the structure was properly calculated (see Table 3.1). 
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Figure 3.25. Distribution of the NOE interactions of Tau(254-268) bound to F-actin. 
(a) Distribution of the distance constraints as a function of the residue number of the peptide. Upper 
distance limits are classified according to their range as intra and sequential constraints (white bars) and 
medium-range (grey bars). (b) Overview of sequential and medium-range NOEs in various secondary 
structural elements. Horizontal lines connecting the corresponding proton positions indicate short 
distances between atoms (≤ 6Å). The thickness of the lines is proportional to the intensity of the observed 
NOE. 
The NOE connectivity, which is the hallmark for the secondary structure element and the 
number of NOEs per each residue are shown in Figure 3.25a. Here white bars represent 
sequential NOEs while medium-range interactions are represented by grey bars. 
 
Figure 3.26. Structure of Tau(254-268) bound to F-actin.   
(a) Backbone superposition of the best 10 structures of the peptide bound to F-actin as calculated by tr-
NOESY experiments. Hydrophobic residues are highlighted in yellow. (b) Cartoon representation of the 
α-helical structure adopted by the peptide upon binding. 
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Note, especially in Figure 3.25b, that secondary structure elements are distributed around the 
whole sequence meaning that the peptide is fully structured. A ribbon representation of the best 
10 calculated conformers are shown in Figure 3.26a. Interestingly hydrophobic residues I206 and 
L266 are pointing towards the same direction, which could be an important clue about the nature 
of the binding. The structure validation analysis revealed that the peptide adopts an α-helix 
conformation between residues I260 and E264 as it can be seen in Figure 3.26b.  
3.3.4. Structure calculation of Tau(254-290) bound to F-actin 
Provided that Tau(254-268) does not promote the bundle formation of F-actin (Figure 3.14d) we 
decided to determine the structure of a larger construct having the bundling capability. With this 
information we might be able to derive a connection between structure and function. Therefore 
we decided to calculate the structure of the peptide Tau(254-290), which is 22 residues larger 
than Tau(254-268) promotes F-actin bundle (Figure 3.14a). 
The sequential assignment of this peptide was done as in the previous case by using a 
combination of a TOCSY and a NOESY spectrum. For the experiment a sample containing 800 
 µM peptide and 26.6  µM F-actin was prepared in a 30:1 ratio. To discard any diffusion effect 
due to the high molecular weight of the complex 5 different NOE spectra were acquired at 
different mixing times ranging from 50 up to 250 ms. Analysis of NOE signal intensities from 
cross-peaks S262HA-N265H and D283HA-N286H as a function of NOE mixing time showed 
that spin diffusion, does not significantly contribute to NOE intensities at used mixing times 
(Figure 3.27a). For the structure calculation the spectrum acquired with a mixing time of 100 ms 
was used. As in the previous case, only medium range NOE contacts were used with the lower 
and upper limits set to 1.8 Å and 6.0 Å respectively. Two different regions of the spectra from 
Tau(254-290) are shown in Figure 3.27b and Figure 3.27c. In both cases NOE peaks appeared 
because of the transferred magnetization from the peptide in bound to free state upon addition of 
F-actin.  
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Figure 3.27. NOE intensity buildup curve for two NOE cross peaks. 
(a) The buildup curves for the NOE cross-peaks S262HA-N265H (blue) and D283HA-N286H (red) are 
presented as a function of the mixing times 50, 80, 100, 150 and 250 ms. (b,c), Two regions of 
superimposed NOESY spectra from Tau(254-290) in absence (blue) and in presence (red) of F-actin. 
A total of 778 distance restraints were collected with 313 intra-residue, 283 sequential and 182 
medium range interactions as can be seen in Table 3.2. 
The distribution of the restraints are presented in Figure 3.28a where color code is similar to the 
previous case. In the histogram white bars represent sequential NOEs while medium-range 
interactions are represented by grey bars. C- and N-termini are structured whereas a flexible 
region is located at the middle of the sequence (Figure 3.28b). This flexible region correlates 
with the PGGG motive from P270 to G273.  
Structure validation revealed a nice Ramachandran statistic (see Table 3.2) with 91.2% of the 
residues in the most favored region whereas only 1.4% of them were in disallowed regions. The 
N-terminal part of the 20 calculated conformers were properly aligned with a RMSD of 1.139 Å 
if only backbone atoms are considered or 1.966 Å for heavy atoms. The C-terminal part is also 
structured although the RMSD for aligned residues from I278 to V287 is a bit higher. This may 
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indicate that the C-terminal part is transiently structured when bound to F-actin or the binding is 
less strong in comparison to the N-terminus. 
Table 3.2. Structural statistics of Tau(254-290) bound to F-actin 
Structural statistics for 20 final conformers of Tau(254-290) bound to F-actin 
Number of restraints 
     Intra residue NOE (|i-j|=0) 
     Sequential NOE (|i-j|=1) 
     Medium range NOE (1<|i-j|≤4) 
     NOE violations > 0.5 Å/structure 
Ramachandran plot statistics 
     Residues in most favored regions 
     Residues in additionally allowed regions 
     Residues in generously allowed regions 
     Residues in disallowed regions 
778 
313 
283 
182 
0 
 
91.2% 
6.4% 
0.0% 
1.4% 
 
RMSD from the average structure Residues (256-267) Residues (278-287) 
All backbone atoms (Å) 
     Heavy atoms (Å) 
1.139 
1.966 
1.864 
2.113 
 
Figure 3.28. Distribution of the NOE interactions for Tau(254-290). 
(a) Distance constraints distribution as a function of the residue number of the peptide. Upper distance 
limits are classified according to their range as intra and sequential constraints (white bars) and medium 
range (grey bars). (b) Overview of sequential and medium-range NOEs in various secondary structural 
elements. 
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Figure 3.29. Ribbon representation of the best 10 conformers from Tau(254-290). 
(a) 10 lowest-energy conformers of F-actin bound Tau(254-290). Structures were aligned from N255 to 
H268. Hydrophobic residues are colored orange. In addition, K259 (blue) and S262 (light green) are 
highlighted. (b) 10 lowest-energy conformers of F-actin bound Tau(254-290) aligned from residue Q276 
to V287. (c) Cartoon representation of Tau(254-290) in bound state to F-actin. 
The best 10 calculated conformers are shown in Figure 3.29a and Figure 3.29b. The peptide 
binds to F-actin in an extended conformation, which is in agreement with the lack of long-range 
interaction. Protein structure validation revealed a short  α-helix in the N-terminus from residue 
G261 to K267 Figure 3.29c. If the 10 conformers are aligned, hydrophobic residues I260 and 
L266 are oriented in the same direction while S262 remains in the same plane. In this specific 
orientation K259 is pointing toward the opposite direction. Downstream of K267 an unstructured 
region follows, which separates the K259-K267 helix from a second helical region formed by 
V275 to L284 (Figure 3.29b). This region contains the aggregation-prone 
hexapeptide 275VQIINK280. Besides the hydrophobic hexapeptide, two additional hydrophobic 
residues, L282 and L284 are present, resulting in a larger hydrophobic surface of the helix 
(Figure 3.29b). Due to the lack of long-range contacts, the relative orientation of the two α-
helices was not defined in the 3D structure. Instead, the presence of a proline residue and three 
glycines in the linker region (the conserved PGGG motif) suggests that the intervening region 
remains flexible, enabling a variety of different relative orientations of the two helices. 
3.3.5. Structure calculation of Tau(292-319) bound to F-actin 
The structure calculation for a consecutive peptide Tau(292-319) was also performed. The 
sequential assignment of this peptide was performed using the same methodology as before. For 
the structure calculation of the Tau peptide a mixture of Tau(292-319) and F-actin (30:1 ratio) 
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was prepared. Upon analyzing the NOE spectrum a total of 385 restraints were obtained. From 
them 150 were intra-residue, 166 sequential and 69 medium-range contacts as shown in Table 
3.3. 
Structure validation revealed that 71.9% of the residues were in the most favored regions 
whereas 5.7% of them were in disallowed regions (Table 3.3). The N-terminal part of the 20 
calculated conformers between residue S293 and V300 can be aligned with a RMSD of 0.53 Å 
considering only the backbone atoms or 1.35 Å for heavy atoms. The C-terminal part is also 
structured with RMSDs of 0.83 Å and 1.49 Å for backbone atoms and heavy atoms respectively. 
The NOE connectivities and the number of NOEs per residue are shown as a histogram in Figure 
3.30a. Unlike the previous peptides a major number of distance restraints are observed on the C-
terminus than for the N-terminus. The restraints distribution through the sequence (Figure 3.30b) 
also shows that the C-terminus is more structured in agreement to what is shown in Figure 3.30a. 
Table 3.3. Structural statistics of Tau(292-319) bound to F-actin 
Structural statistics for 20 final conformers of Tau (254-290) bound to F-actin 
Number of restraints 
     Intra residue NOE (|i-j|=0) 
     Sequential NOE (|i-j|=1) 
     Medium range NOE (1<|i-j|≤4) 
     NOE violations > 0.5 Å/structure 
Ramachandran plot statistics 
     Residues in most favored regions 
     Residues in additionally allowed regions 
     Residues in generously allowed regions 
     Residues in disallowed regions 
385 
150 
166 
69 
0 
 
71.9% 
14.3% 
8.1% 
5.7% 
 
RMSD from the average structure Residues (293-300) Residues (313-319) 
All backbone atoms (Å) 
     Heavy atoms (Å) 
0.531 
1.348 
0.832 
1.491 
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Figure 3.30. Distribution of the NOE interactions for Tau(292-319). 
(a) Distribution of the distance constraints as a function of the residue number of the peptide. Upper 
distance limits are classified according to their range as intra and sequential constraints (white bars) and 
medium-range (grey bars). (b) Overview of sequential and medium ranges NOEs in various secondary 
structural elements. Horizontal lines connect the protons, which are separated by short distances (≤ 6Å) 
while the thickness of the lines is proportional to the intensity of the observed NOE. 
The best 10 calculated conformers are presented in Figure 3.31a and b. The peptide binds to F-
actin in an extended conformation due to no long-range interactions were observed. Protein 
structure validation of 20 different conformers reveals a short α-helix in the C-terminus from 
residue L315 to V318. A cartoon representation of the peptide is shown in Figure 3.31c where 
hydrophobic residues are highlighted at the C-terminal part.  
 
Figure 3.31. Ribbon representation of the best 10 conformers from Tau(292-319). 
(a) The conformers were aligned toward the C-terminus from V313 to T319 where a short α-helix from 
residues L315 to V318 can be seen. (b) Similarly, the N-terminal part was aligned from residue S293 to 
V300. (c) Cartoon representation of Tau(292-319) in bound state to F-Actin. Hydrophobic residues on the 
α-helix are highlighted. 
  
 
Results 
 
  
82 
3.4. Docking the Tau(254-290) structure on F-actin surface 
To derive a structural model for the Tau/F-actin binding site, we integrated the information that 
was obtained from the peptide Tau(254-290) with the 3D structure of cofilin-decorated F-actin 
(Figure 1.10a). To this end, the NOE-based 3D structure of Tau(254-290) was docked to the 
solvent-exposed, hydrophobic pocket of actin within the actin filament structure using the 
software Haddock (Gorbatyuk, Nosworthy et al. 2006). The selected active residues on F-actin 
were listed in Materials and Methods and are highlighted in cyan color on Figure 3.32. 
Surrounding residues were considered as passives while the full-length peptide was docked. 
Haddock clustered 192 complex structures in four clusters, representing 96.0 % of the water-
refined Haddock models. Within the highest scoring cluster (Table 3.4), the N-terminal α-helix 
of Tau(254-290) was bound to the hydrophobic pocket of F-actin (Figure 3.33a). In agreement 
with the importance of hydrophobic interactions (Figure 3.19), Tau residues I260 and L266 made 
hydrophobic contacts with F352 and I345 from actin, respectively.  
 
Figure 3.32. Active residues on F-actin used for docking calculation. 
3D CryoEM-based structure of F-actin (pdb: 3J0S (Galkin, Orlova et al. 2011)). Active residues for 
docking calculation are represented in cyan color. 
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Table 3.4. Statistic parameters from the lower score cluster from docking. 
HADDOCK score 1.6 ± 1.1 
Cluster size 161 
RMSD from the overall lowest-energy structure 1.0 ± 0.8 
Van der Waals energy -54.4 ± 8.2 
Electrostatic energy -291.9 ± 105.8 
Desolvation energy 110.5 ± 17.1 
Restraints violation energy 38.8 ± 8.07 
Buried Surface Area 1823.0 ± 96.1 
Z-Score -1.5 
 
 
Figure 3.33. Superposition of 3D structures of both cofilin and Tau(250-290) in complex with F-
actin. 
(a) Crystal structure of cofilin (blue) in complex with F-actin (pink; PDB id: 3J0S), superimposed onto 
the F-actin bound form of Tau(254-290) as derived from protein-protein docking (black). Side chains of 
selected residues are shown. (b) Sequence alignment of cofilin with residues 268-254 of Tau. 
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Next, we compared the docking model of the Tau(254-290)/F-actin complex with the 3D 
structure of cofilin-decorated F-actin (Figure 3.33a). The comparison showed that the α-helix of 
Tau(254-220 290) is positioned in the binding pocket in a very similar way as the recognition 
helix of cofilin (blue). L266 of Tau(254-290) is only 4 Å away from I345 on F-actin, while the 
HE atom of the cofilin residue M115 is 3.1 Å separated from the HG2 atom of I341 in actin. In 
addition, I260 of Tau(254-290) was found in a similar location as I124 from cofilin. In 
agreement with the structural similarity, the involved sequences from cofilin and Tau can be well 
aligned (Figure 3.33b). Optimal sequence alignment was achieved, when the sequence of Tau 
was inverted (Figure 3.33b), indicating an inverted orientation of its recognition helix when 
compared to cofilin (Figure 3.33a). 
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4. Discussion 
4.1. The interaction of Tau with actin  
Tau and other microtubule-associated proteins, such as MAP2, not only bind to microtubules but 
also to filamentous actin, which results in cross-linking and bundling of actin filaments (Griffith 
and Pollard 1982, Selden and Pollard 1983, Sattilaro 1986, Yamauchi and Purich 1993, 
Cunningham, Leclerc et al. 1997, Biernat, Wu et al. 2002, He, Wang et al. 2009, Elie, Prezel et 
al. 2015). The interaction of Tau with actin is important for neurite outgrowth and synaptic 
dysfunction (Knops, Kosik et al. 1991, Biernat and Mandelkow 1999, Fulga, Elson-Schwab et al. 
2007). Pathogenic forms of Tau have been connected to the formation of actin-rich rods 
(Whiteman, Gervasio et al. 2009), which were found to induce neurodegeneration in Drosophila 
neurons (Fulga, Elson-Schwab et al. 2007). In addition, Tau-induced neurotoxicity is associated 
with increased F-actin levels (Fulga, Elson-Schwab et al. 2007), and Tau-induced remodeling of 
the actin cytoskeleton can cause plasma membrane blebbing (Torres-Cruz, Rodriguez-Cruz et al. 
2016). 
G-actin form gels in presence of Tau (Yamauchi and Purich 1993), most probably because of a 
direct interaction between Tau and monomeric actin. In addition, preincubation of the 3-repeat 
isoform of Tau, Tau23, the proline-rich region as well as the MBD with skeletal or non-muscle 
actin promoted actin assembly (He, Wang et al. 2009). Actin monomers also inhibit the 
association of Tau with tubulin(Farias, Munoz et al. 2002). 
G-actin binding proteins regulate the size, localization and dynamics of the large pool of 
unpolymerized actin in cells (Dominguez 2004). G-actin binding proteins include profilin, cofilin 
and formin, which interact with G-actin and regulate their incorporation into filament ends 
controlling actin dynamics in cells. Although Tau and Tau peptides bind to G-actin, they 
promote and not inhibit G-actin assembly, indicating that Tau cannot be considered as an actin 
sequestering protein.  
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4.1.1. Tau binds to G-actin 
To study the interaction between Tau and monomeric actin, we first determined the Tau/G-actin 
binding affinity through the use of NBD-labeled G-actin. The change in fluorescence of NBD-
labeled actin has been broadly used for studying the interaction between actin and other actin-
binding proteins (Detmers, Weber et al. 1981, Bryan and Kurth 1984, Hertzog, Yarmola et al. 
2002, Ojala, Paavilainen et al. 2002, Mattila, Quintero-Monzon et al. 2004). We found that Tau 
binds to G-actin with an affinity of 0.091 ± 0.007 µM and decreased the NBD fluorescence in a 
45 %. This result is in agreement to the reported by He, Wang et al (He, Wang et al. 2009) were 
a solid phase assay revealed an affinity of 0.029 ± 0.005 µM for the binding between Tau23 and 
 β/γ-G-actin respectively. R2 domain in hTau40 is not present in Tau23 and therefore one would 
expect different affinities between both Tau isoforms. However, in a self-assembly test a 1.4 
times more peptide from R2 domain (i.e. 287VQSKCGSKDNIKHVPGGG305) was required to 
promote a comparable assembly effect than a peptide from R1 domain (Moraga, Nunez et al. 
1993). This means that R2 has a lower contribution to the interaction than other Tau regions 
involved in binding and explains why the affinities between hTau40 and Tau23 are comparable. 
We have determined that two fragments of Tau, R1 (254KNVKSKIGSTENLKHQPGGG 
KVQIINKKLDL284) and K18 (repeat region of Tau) bind to G-actin with affinities 0.76 ± 0.06 
µM and 0.21 ± 0.03 µM respectively. If affinities of hTau40, K18 and Tau(254-284) (Figure 
3.1d-f ) are compared, it can be inferred that interaction of Tau and G-actin depends on the 
number of interacting residues. Interestingly a similar peptide from the MBD of MAP-2 and 
MAP-4 promoted bundles of F-actin (Moraga, Nunez et al. 1993). 
4.1.2. The MBD and proline-rich region of Tau interact with G-actin 
Evidences about the interaction between Tau23, the shortest Tau isoform in the human brain (see 
Figure 1.3), and G-actin had been previously reported (He, Wang et al. 2009). The authors 
showed, by using solid phase assay, that Tau23 binds to G-actin and promoted actin assembly 
being both the proline-rich and repeat regions responsible for the interaction. However both 
regions conserved the bundling effect of full-length Tau23. 
Here we demonstrated, by means of NMR spectroscopy, that hTau40, the largest isoform of Tau, 
interacts with G-actin as well. In agreement with He, Wang et al. the study revealed that residues 
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from both the proline-rich and the repeat regions of Tau are those in close contact with G-actin 
(Figure 3.3). If the repeat region on the intensity plot is analyzed binding hot spots separated by 
flexible linkers in the Tau sequence can be identified. Interestingly, residues from L114 to T123 
in the region between N2 and P1 (see top panel on Figure 3.3), which has an alpha helical 
propensity (Mukrasch, Bibow et al. 2009), are also involved in binding to G-actin. In addition 
selected regions of K18, adopt α-helical conformations upon binding to micelles (Barre and 
Eliezer 2013). All together suggests, in agreement with our finding, that G-actin might also 
recognize α-helical structures of Tau. 
4.1.3. Different Tau motifs bind to the same region of G-actin 
Competition experiments between Tau and Tau peptides from the identified binding hot spots 
were performed to determine whether these Tau fragments bind to the same site on the actin 
surface. Peptides from the MBD (residues 254-290 and 292-319) as well as a peptide from the 
P2 region (residues 211-242) detached full-length Tau from the actin surface. This suggests that 
the three Tau peptides bind to a common region in actin where they interact in a competitive 
manner (Figure 4.1a). Other possibility would be a cooperative effect between the involved 
regions so that when one of them is affected the rest would feel the effect as a consequence.  
That Tau binds to a single region on the G-actin surface by using distinct segments across the 
MBD opens the possibility that one molecule of Tau can cross-link at least two molecules of 
actin (Figure 4.1b). Two cross-linked molecules of actin may serve as a core to assemble new 
actin filaments. Unfortunately the fluorescence-binding assay does not consider stoichiometry 
bigger than one. However, this problem could be addressed by using Isothermal Calorimetric 
Titration (ITC). 
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Figure 4.1. Pictorial representation of Tau/G-actin interaction. 
(a) Tau (black line) interacts with G-actin (pink) by means of short regions (red lines) and recognizes a 
specific region on G-actin surface. (b) Cartoon representation of the mechanism through which Tau might 
bring actin monomer close each other promoting actin polymerization. 
4.1.4. Tau binds to the hydrophobic pocket of G-actin 
The dynamics and reorganization of actin filaments observed in motile cells requires the 
availability of actin monomers to be tightly regulated. This regulation is achieved by a group of 
highly conserved G-actin-binding proteins using different mechanisms of action (Lee and 
Galbraith 1992, Pollard and Borisy 2003, Dominguez and Holmes 2011). In motile cells the 
presence of a large pool of actin monomers is required to allow rapid filament extension. 
Monomer-sequestering proteins are those in charge of this job as a response to different signaling 
process. 
Cibulout, a protein from Drosophila, is one of the proteins having a high sequence similarity 
with Thymosin-β4, the major variant of the sequestering G-actin β-thymosins (Boquet, 
Boujemaa et al. 2000). However, in presence of caped actin, Cib has a profilin-like function 
participating in actin assembly at the barbed end (Pollard and Cooper 1984, Pring, Weber et al. 
1992, Boquet, Boujemaa et al. 2000). As mentioned in section 1.4.3.1, Cib(D1), one of the three 
repeats of Cib binds to G-actin with an affinity of ~2.5 µM (Boquet, Boujemaa et al. 2000, 
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Hertzog, Yarmola et al. 2002). In addition, Cib adopts an α-helical conformation upon binding to 
the hydrophobic pocket of actin (Hertzog, van Heijenoort et al. 2004).  
To address whether Tau binds to the hydrophobic pocket of actin, we performed competition 
experiments between Tau and Cib(D1) in presence of G-actin. In this experiment G-actin was 
previously incubated with LatB, a drug that inhibits actin assembly. The experiment revealed 
that both Tau and Cib(D1) share the same binding site on actin. A 20-fold excess of Cib(D1) 
detached Tau from the actin surface (Figure 3.7), a result that was further confirmed by STD 
were short Tau fragments competed with Cib for binding to G-actin (Figure 3.8). The STD 
experiments also supported the hypothesis that short Tau peptides bind to the same region of G-
actin as full-length Tau. In addition, competition experiments with LatB suggested that Tau does 
not bind to actin’s nucleotide-binding pocket. Furthermore, PRE data confirmed not only that 
Tau binds to the hydrophobic pocket but also that the proline-rich and repeat regions are those in 
close contact with actin. These regions involve the 
hexapeptides 275VQIINK280 and 306VQIVYK311, which are known to be prompt to Tau 
aggregation in AD (von Bergen, Friedhoff et al. 2000). 
4.1.5. Influence of phosphorylation of Tau at KXGS motifs on the 
interaction with G-actin 
Tau undergoes several post-translational modifications that influence its function, aggregation 
and toxicity (Gong, Liu et al. 2005). One of the most important post-translational modification is 
phosphorylation, because Tau is hyper-phosphorylated in the brains of patients with Alzheimer’s 
disease (Bancher, Brunner et al. 1989). It has been reported that phosphorylation of serine 
residues at KXGS motifs in the repeat domain of Tau, such as S262, strongly reduce the affinity 
of Tau for microtubules (Biernat, Gustke et al. 1993). Here we demonstrated that 
phosphorylation of Tau(254-284) on S262 decreases the affinity of the peptide to G-actin (Figure 
3.1c and g). Interestingly regions, which are in close proximity to G-actin, involve the KXGS 
motifs (Figure 3.9d) whose phosphorylation attenuates the interaction with actin. This suggests 
that the KXGS motifs of Tau should be involved in binding in both Tau/MT and Tau/actin 
interactions. Although we have said that the interaction between Tau and actin should have 
mainly a hydrophobic nature the existence of local electrostatic contribution cannot be discarded. 
If we assume that the interaction of the KXGS motifs of Tau are those having electrostatic 
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contacts with actin we can argue that when serine is phosphorylated it acquires a negative charge 
generating an electrostatic repulsion in the binding site. 
4.2. Relevance of the interaction between Tau and G-actin 
Although the interaction between Tau and monomeric actin was already reported nothing was 
known about the mechanism of interaction. Here we reported not only a novel mechanism for the 
Tau/G-actin interaction but also the Tau residues involved in binding. So far several actin-
binding proteins have been identified to bind at the hydrophobic pocket of actin adopting an α-
helical conformation upon binding (Dominguez 2004). The fact that Tau binds at this region, as 
suggested by competition with Cib and PRE data, could indicate that Tau might adopt alpha 
helical conformation as well. Furthermore selected residues in K19, a Tau construct including 
R1, R3 and R4 regions on the MBD, is known to adopt alpha helical conformation upon binding 
to micelles (Barre and Eliezer 2006). The Tau segments having an α-helical conformation upon 
binding to micelles are L253-G261, L315-G323 and F346-G355. Interestingly these residues are 
also involved in binding to actin (see section 3.1.4.2.2). All together suggests that Tau could 
have an important role in the actin turnover, facilitating the actin polymerization and contributing 
to the dynamics of actin in cells. This conclusion further support the correlation between the loss 
of spines and the presence of Tau in dendrites in Alzheimer´s disease (Zempel, Thies et al. 
2010).We have shown that Tau phosphorylation decreases the affinity of the Tau/G-actin 
interaction. Furthermore Tau phosphorylation is associated with Tau aggregation in AD (Martin, 
Latypova et al. 2013). Therefore this could explain the correlation between Tau neurotoxicity 
and alterations of actin organization in animal models of Alzheimer’s disease (Fulga, Elson-
Schwab et al. 2007). 
4.3. Tau interacts with F-actin 
Misfolding and aberrant accumulation of the microtubule-associated protein Tau is a 
pathological hallmark of Alzheimer’s disease (AD) (Williams 2006). Occurrence of Tau deposits 
correlates with the loss of cognitive functions in AD, suggesting a connection between Tau and 
synaptic transmission (Giannakopoulos, Herrmann et al. 2003). Because Tau directly interacts 
with F-actin and regulate its stability (Yamauchi and Purich 1993, Fulga, Elson-Schwab et al. 
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2007, He, Wang et al. 2009, Frandemiche, De Seranno et al. 2014), the interaction of Tau with F-
actin might influence synaptic plasticity (Hotulainen and Hoogenraad 2010). In agreement with 
the importance of the Tau/F-actin interaction, actin-rich paracrystalline inclusions, so-called 
Hirano bodies, are found in brain histopathological samples of AD and related tauopathies 
(Hirano 1994, Makioka, Yamazaki et al. 2014). In addition, it was recently shown that 
acetylation of Tau modulates actin polymerization and enhances synaptic dysfunction (Tracy, 
Sohn et al. 2016).  
The human central nervous system contains six different isoforms of Tau, which differ in the 
number of N-terminal inserts and have either three or four imperfect repeats in their C-terminal 
half (Figure 1.3) (Weingarten, Lockwood et al. 1975). The repeats are important for binding of 
Tau to microtubules and F-actin (Butner and Kirschner 1991, Gustke, Trinczek et al. 1994). 
Other microtubule-associated proteins from the MAP2 family also bind to actin filaments 
through their repeat domain (Griffith and Pollard 1982). In addition, certain fragments of the 
repeat-domain of Tau are able to bind actin and promote actin bundling (Moraga, Nunez et al. 
1993).  
In agreement with previous findings, we show that Tau binds with high-affinity to filamentous 
actin, resulting in F-actin bundling. Our results support the previous reports about the interaction 
between Tau and F-actin and demonstrate that specific regions inside the Tau sequence are the 
responsible for this interaction. The proline-rich and repeat regions are involved in binding, an 
observation that is in agreement with previous reports. Interaction with the proline-rich region is 
primarily of electrostatic nature. In contrast, short hydrophobic residue stretches in the repeat 
domain bind to the hydrophobic pocket between subdomain 1 and 3 of actin (Figure 3.18b). 
In agreement with Correas, Padilla et al. our result showed that short Tau motives like Tau(254-
290) and Tau(292-319) are able to bundle F-actin while a shorter construct having only 15 
residues like Tau(254-268) failed in bundling actin filaments (Figure 3.14). 
4.4. Tau binds to F-actin in a similar fashion than to G-actin: as 
seen by NMR 
If the intensity plots and affinities from Tau/G-actin and Tau/F-actin interactions are compared is 
clear that Tau binds similarly in both cases to G- or F-actin. Thus it is reasonable to think that 
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Tau binds also on the hydrophobic pocket of F-actin, which is exposed to the solvent in the 
filamentous form of actin (Dominguez 2004, Dominguez and Holmes 2011). NMR-based 
competition experiments and co-sedimentation assays with cofilin in presence of Tau and F-actin 
confirmed this hypothesis. On the other hand PRE data revealed six defined peaks corresponding 
to residues K243-V246, K259-K268, Q276-K290, S305-Y310, S320-H330 and K375-F378 are 
involved in binding (Figure 3.18b), which are nearly the same in case of PRE data from G-actin. 
The F-actin-interacting Tau residues as in case of the interaction with G-actin are separated from 
each other by flexible linkers, which enable a high degree of dynamics and multivalency in the 
Tau/F-actin interaction. 
The fact that Tau binds on the same place than cofilin which at the same time share the binding 
site with gelsolin (Mclaughlin, Gooch et al. 1993) may suggest that these proteins have similar 
functions. Nevertheless the binding of Tau to monomeric actin suggests that Tau might have also 
a profilin-like function as mediator of the actin assembly. 
We further investigated the nature of the interaction between Tau and F-actin using a NMR-
based salt titration experiment (Figure 3.19a). The experiment revealed that even at high salt 
concentration, regions form the repeat and P2 regions of Tau were still bound to F-actin in 
agreement to reported in 2009 (He, Wang et al. 2009). This is a surprise if we consider the fact 
that Tau binds on the hydrophobic pocket of actin where hydrophobic interaction should 
command. The fact that this interaction has an important hydrophobic contribution could be 
particularly important in cell were physiological conditions can minimize electrostatic 
interactions. 
4.5. Phosphorylation of Tau affects its binding to F-actin 
Tau undergoes several post-translational modifications that influence its function, aggregation 
and toxicity (Gong, Liu et al. 2005). An important post-translational modification is 
phosphorylation, because Tau is hyper-phosphorylated in the brains of patients with Alzheimer’s 
disease (Bancher, Brunner et al. 1989). Phosphorylation of serine residues at KXGS motifs in the 
repeat domain of Tau, such as S262, strongly reduce the affinity of Tau for microtubules 
(Biernat, Gustke et al. 1993). In addition, phosphorylation by endogenous protein kinases 
inhibits the ability of Tau and MAP2 to cross-link and bundle actin filaments (Selden and Pollard 
1983, Sattilaro 1986). Consistent with these data, we showed that phosphorylation of Tau by 
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MARK2 reduces the affinity of Tau for F-actin (Figure 3.20). In addition, specific 
phosphorylation at S262 decreased the F-actin affinity of Tau(254-284) (Figure 3.21). 
While our as well as previous biophysical studies demonstrated that phosphorylation at the 
KXGS motifs decreases the affinity of Tau for both microtubules and F-actin, cellular studies 
showed that phosphorylation of the KXGS motifs cause MAP-2 and Tau to localize to the actin 
cytoskeleton (Ozer and Halpain 2000, Biernat, Wu et al. 2002). In addition, phosphorylated Tau 
is recruited to actin-cofilin rods, which might lead to neuropil threads (Whiteman, Gervasio et al. 
2009). The combined data suggest that phosphorylation of Tau at KXGS motifs attenuates the 
direct interaction with microtubules and F-actin, but fosters the interaction with actin-containing 
structures, in which other proteins such as cofilin, might mediate the interaction with 
phosphorylated Tau.  
4.6. Insights into the structure of Tau bound to F-actin 
Microtubule-associated proteins (MAPs) bind to, stabilize and promote assembly of 
microtubules (Lee 1993, Mandelkow and Mandelkow 1995). In addition, MAPs bundle actin 
filaments and cross-link the cellular cytoskeleton formed by microtubules and actin filaments 
(Figure 4.2) (Griffith and Pollard 1982, Selden and Pollard 1983, Sattilaro 1986, Yamauchi and 
Purich 1993, Biernat, Wu et al. 2002, He, Wang et al. 2009). The interaction of MAPs with actin 
is important for neurite outgrowth (Knops, Kosik et al. 1991, Biernat and Mandelkow 1999). 
Representative MAPs are MAP1a, MAP1b, MAP2a, MAP2b, MAP2c, MAP4 and Tau, and 
isoforms of these proteins, which are often generated by alternative splicing (Lee 1993).  
As described on section 1.3.1 Tau occurs in six different isoforms in the human central nervous 
system (Butner and Kirschner 1991, Gustke, Trinczek et al. 1994). The Tau isoforms differ in the 
number of N-terminal inserts and have either three or four imperfect repeats in their C-terminal 
half (Weingarten, Lockwood et al. 1975). The imperfect repeats are important for binding to both 
microtubules and actin. In addition, short fragments of the microtubule-binding domain of Tau 
promote actin bundling (Moraga, Nunez et al. 1993). Proteins from the MAP-2 family also bind 
to actin filaments through their repeat domain (Griffith and Pollard 1982). Because a single 
repeat interacts with both monomeric and filamentous actin, but does not bundle actin filaments, 
more than one microtubule-binding repeat is believed to be required for bundling of filamentous 
actin (Correas, Padilla et al. 1990).  
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Figure 4.2. Schematic representation of the importance of MAPs for the cellular cytoskeleton. 
MAPs (black) regulate microtubule dynamics (blue), bundle actin filaments (yellow) and cross-link actin 
filaments and microtubules. Aberrant interaction of Tau with F-actin is associated with synaptic 
dysfunction in Alzheimer’s disease. 
As Tau is intrinsically disordered in solution the knowledge of its 3D structure upon binding to 
actin is primordial to understand the mechanism of the interaction and its function in terms of F-
actin stabilization. We are particularly interested how Tau promotes the actin assembly and 
cytoskeletal network stability. Extracting structural information from the Tau/F-actin complex, 
which has a size on MDa order, is challenging because of the size limitation of NMR 
spectroscopy. Nevertheless, we have already shown that Tau bind to G- and F-actin by means of 
defined hot spots separated by flexible linkers. Based on this finding we can use the so-called 
“divide and conquer strategy” to derive the structure of Tau bound to F-actin.  
If the ligand is weakly bound and there exists a fast exchange between free and bound forms of 
the ligand, detailed structural and dynamic information can be obtained by using tr-NOE and 
STD measurements (sections 2.10.2 and 2.10.5). STD experiment revealed that short Tau 
peptides are able to bind F-actin in a micro to millimolar range (Figure 3.22). The observation of 
a STD effect for peptides like Tau(254-268), Tau(254-290) and Tau(292-319) suggests that these 
peptides are suitable subjects for structure calculation using the tr-NOE approach. 
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4.6.1. Tau peptides recognizes F-actin by means of an alpha helical motifs 
We further showed that the F-actin-interacting residues in the repeat domain of Tau, fold into 
short α-helices upon binding to filamentous actin (Figure 3.26, Figure 3.29 and Figure 3.31). 
Folding of local regions of Tau into α-helical structure is consistent with the formation of α-
helices in actin-binding proteins, in which the actin-interacting region is intrinsically disordered 
prior to binding to actin (Dominguez 2004, Dominguez and Holmes 2011). The Tau regions that 
fold into α-helical structure include the two hexapeptides, 275VQIINK280 and 306VQIVYK311, at 
the beginning of repeats R2 and R3 (Figure 3.29b and Figure 3.31). The two hexapeptides are 
important for aberrant aggregation of Tau into paired helical filaments (von Bergen, Friedhoff et 
al. 2000). In solution, the two hexapeptides populate extended structure (Mukrasch, Bibow et al. 
2009), are found in cross-β structure in amyloid fibrils (Andronesi, von Bergen et al. 2008, 
Daebel, Chinnathambi et al. 2012), but fold into α-helical structure in complex with F-actin (Fig. 
3.29). In addition to the two hexapeptides, the N-terminal halves of each of Tau’s four 18-residue 
aminoacid repeats (Goode and Feinstein 1994) bind to F-actin’s hydrophobic pocket and fold 
into α-helix (Figure 3.29). Consistent with the compatibility of these regions for α-helical 
conformation, Tau residues 253-260, 315-322 and 345-354 populate helical structure in the 
presence of detergent and upon binding to membranes (Barre and Eliezer 2006). Docking of 
experimentally determined Tau helices to the F-actin surface together with sequence alignment 
showed that the overall position of the interacting Tau and cofilin helices is well conserved, but 
the directionality of their polypeptide chain is inverted (Figure 3.33). The directionality of the 
Tau(259-267)-helix is similar to that of the actin interacting helix of toxofilin, an actin-binding 
protein that is secreted into host cells during invasion (Dominguez and Holmes 2011). The 
KXGS motif, which contains S262, is located in one of the F-actin interacting helices of Tau 
(Figure 3.29a). The side chain of S262 points towards actin’s hydrophobic binding pocket 
(Figure 3.33a), providing a structural explanation for the lower affinity of S262-phosphorylated 
Tau(254-284). S262 may share hydrogen bound with Y143 in actin because they are only 1.6 Å 
away in the docked structure (Figure 3.33a), nevertheless this interaction may be affected when 
the side chain of serine get phosphorylated. Taken together the data show that Tau utilizes a 
structural mechanism for binding to F-actin that is used by several actin-binding proteins. 
  
 
Discussion 
 
  
96 
4.6.2. Rolle of Tau in the cytoskeletal network organization 
Binding of Tau and MAP2 to filamentous actin results in actin cross-linking and filament 
bundling (Selden and Pollard 1983, Sattilaro 1986, Butner and Kirschner 1991, Wang, Grundke-
Iqbal et al. 1996, Dominguez, Boelens et al. 2003, Hotulainen and Hoogenraad 2010, Kadavath, 
Jaremko et al. 2015). At the same time, binding to F-actin can be retained, but the cross-linking 
activity disrupted. For example, a C-terminal fragment and a peptide corresponding to the second 
microtubule-binding repeat bind actin, but are incapable of mediating actin cross-linking 
(Sattilaro 1986, Correas, Padilla et al. 1990). These findings suggest that multiple domains of 
Tau might be required for actin cross-linking. Consistent with this hypothesis, we showed that a 
single Tau helix is sufficient for binding to F-actin, but at least two helices, which are separated 
by a flexible linker, are required for cross-linking activity (Figure 3.14d and Figure 3.26). On 
this basis, we developed a model, in which two helical regions in Tau are bound to two different 
actin filaments (Figure 4.3). Because Tau contains seven actin-binding segments (Figure 3.18), 
up to seven actin filaments could be linked together by a single Tau molecule. 
 
Figure 4.3. Mechanistic model of the Tau-induced F-actin bundles. 
Schematic representation of cross-linking of actin filaments by α-helices of Tau, which are separated by 
flexible linkers. Each α-helix (shown in red) is bound to a hydrophobic actin pocket in a neighboring 
filament (grey and light blue). 
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Figure 4.4. Sequence alignment of the repeat domains of MAP2c and Tau. 
Tau residues, which bind to F-actin, are marked by red open bars, experimentally proven F-actin induced 
helical structure by red filled bars, and microtubule-binding sites in orange. KXGS motifs are highlighted. 
Steric constraints are minimized by the presence of flexible linkers between the seven actin-
binding segments. In addition, the excess positive charge, which is present in the repeat domain 
of Tau, will decrease electrostatic repulsion between the negatively charged filament surfaces. 
Because of the high sequence conservation in the repeat domain between Tau and other 
microtubule-associated proteins such as MAP2c (Figure 4.4), our data suggest that the described 
mechanism for actin cross-linking is more widely applicable. 
The interaction between actin filaments and microtubules is important for cellular processes 
including cell division, vesicle and organelle transport, axonal growth and migration (Rodriguez, 
Schaefer et al. 2003). Tau mediates interactions between microtubules and actin in neuronal 
growth cones, where Tau-mediated cytoskeletal interactions promote morphological changes. In 
vitro, Tau binds simultaneously to microtubules and actin filaments (Elie, Prezel et al. 2015). We 
previously showed that the Tau residues 168-185, 224–237, 245–253, 269–284, 300–313, and 
375-398 bind to microtubules at the interface between tubulin heterodimers (Figure 4.4) 
(Kadavath, Hofele et al. 2015). Thus, when both F-actin and microtubules are present, they 
compete for binding to residues 245-246, 275-284 and 305-313, while Tau residues 259-267, 
289-297 and 320-330 will preferentially interact with F-actin (Figure 4.4). Notably, the 
conformations that are induced in Tau upon binding to F-actin and microtubules are very 
different, because F-actin interaction is connected to helix formation (Figure 3.29), while short 
Tau regions fold into a hairpin-like structure in complex with microtubules (Kadavath, Jaremko 
et al. 2015). Thus, the availability of multiple Tau sites for binding to microtubules and F-actin 
together with Tau residues, which are dedicated for binding to only F-actin or microtubules 
(Figure 4.4), enables multivalent cross-linking of microtubules and actin filaments (Figure 4.5). 
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Figure 4.5. Mechanistic model of Tau-mediated F-actin/microtubule network formation. 
Because Tau contains multiple interaction sites for both F-actin (this work) and microtubules, Tau can 
cross-link the cellular cytoskeleton. While short segments in the repeat domain fold into α-helical 
structure (red) in complex with F-actin, Tau residues in complex with microtubules form a microtubule-
specific hairpin structure (orange). 
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